intens
care
unit
icu
contribut
greatli
surviv
patient
trauma
shock
state
lifethreaten
condit
associ
greatli
increas
risk
nosocomi
hospitalacquir
infect
rate
nosocomi
infect
patient
requir
week
advanc
life
support
within
icu
three
fi
time
higher
hospit
patient
requir
icu
care
infect
usual
nosocomi
common
caus
death
directli
indirectli
patient
surviv
earli
period
major
trauma
fullthick
burn
commonli
identifi
ed
caus
multipleorgan
dysfunct
syndrom
although
book
focus
diagnosi
manag
critic
ill
patient
icu
nosocomi
infect
clearli
one
common
seriou
complic
icu
care
usual
consequ
invas
monitor
life
support
therapi
thu
greatli
prevent
appropri
measur
prevent
nosocomi
infect
address
much
learn
past
decad
epidemiolog
nosocomi
infect
acquir
icu
publish
guidelin
prevent
avail
base
increasingli
random
trial
establish
effi
caci
specifi
c
control
measur
knowledg
technolog
asepsi
regard
surgeri
highrisk
medic
devic
suffi
cientli
advanc
appli
consist
risk
nosocomi
infect
greatli
reduc
obtain
meaning
data
rate
nosocomi
infect
form
basi
comparison
within
hospit
especi
among
hospit
also
use
monitor
secular
trend
document
efficaci
lack
effi
caci
control
measur
must
begin
clear
unambigu
defi
nition
although
standard
defi
nition
infect
specifi
c
site
univers
accept
clinician
investig
center
diseas
control
prevent
cdc
publish
defi
nition
purpos
surveil
incid
hospitalacquir
infect
commonli
express
number
infect
per
patient
hospit
highest
burn
unit
surgic
icu
icu
lowbirthweight
neonat
intermedi
risk
medic
icu
pediatr
icu
lowest
risk
coronari
care
unit
tabl
recogn
risk
nosocomi
infect
within
icu
heavili
infl
uenc
length
stay
length
stay
rang
wide
among
icu
hospit
among
differ
hospit
cdc
advoc
use
rate
express
per
patientday
permit
meaning
intrainstitut
especi
interhospit
comparison
furthermor
recogn
power
infl
uenc
exposur
invas
devic
suscept
infect
great
variat
use
devic
among
differ
icu
hospit
among
differ
hospit
cdc
recommend
surveil
deviceassoci
nosocomi
infect
express
infect
per
deviceday
repres
rate
deviceassoci
nosocomi
infect
us
hospit
member
cdc
nation
nosocomi
infect
surveil
system
nni
use
intrahospit
interhospit
comparison
shown
tabl
futur
deviceassoci
infect
rate
sought
accredit
review
joint
commiss
accredit
healthcar
organ
jcaho
infl
uential
organ
continu
move
toward
measur
patient
outcom
effect
way
improv
patient
care
unit
state
approxim
endem
nosocomi
infect
within
icu
catheterrel
urinari
tract
infect
pneumoniasmost
associ
endotrach
intub
mechan
ventilatori
support
patient
hospit
medicalsurg
icu
hour
acquir
nosocomi
bloodstream
infect
commonli
intravascular
devic
postop
surgic
site
infect
intraabdomin
infect
nosocomi
bacteremia
gastrointestin
infect
especi
antibioticassoci
clostridium
diffi
cile
coliti
account
remaind
nearli
nosocomi
infect
icu
caus
aerob
gramneg
bacilli
especi
pseudomona
aeruginosa
enterobact
speci
serratia
marcescen
caus
gramposit
cocci
commonli
coagulaseneg
staphylococci
staphylococcu
aureu
increasingli
resist
enterococci
fig
almost
caus
candida
speci
fi
lament
fungi
aspergillu
zygomycet
increasingli
encount
patient
hematolog
malign
receiv
solid
organ
transplant
virus
respiratori
syncytium
viru
rsv
rotavirus
import
pathogen
pediatr
icu
legionella
speci
account
nosocomi
pneumonia
center
make
effort
diagnos
legionella
infect
box
primari
bloodstream
infect
recogn
pathogen
isol
blood
cultur
pathogen
relat
infect
anoth
site
site
intravascular
devic
one
follow
fever
c
chill
hypotens
follow
common
skin
contamin
isol
two
blood
cultur
drawn
separ
occas
organ
relat
infect
anoth
site
b
common
skin
contamin
isol
blood
cultur
patient
intravascular
access
devic
physician
institut
appropri
antimicrobi
therapi
organ
relat
infect
anoth
site
c
posit
antigen
test
blood
organ
relat
infect
anoth
site
patient
month
age
one
follow
fever
c
hypothermia
c
apnea
bradycardia
one
follow
common
skin
contamin
isol
two
blood
cultur
drawn
separ
occas
organ
relat
infect
anoth
site
site
intravascular
devic
b
common
skin
contamin
isol
blood
cultur
patient
intravascular
access
devic
physician
institut
appropri
antimicrobi
therapi
organ
relat
infect
anoth
site
c
posit
antigen
test
blood
pathogen
relat
infect
anoth
site
clinic
defi
ned
pneumonia
patient
two
serial
chest
radiograph
one
follow
new
progress
persist
infi
ltrate
consolid
cavit
least
one
follow
fever
c
f
recogn
caus
leukopenia
wbcmm
leukocytosi
wbcmm
adult
year
old
alter
mental
statu
recogn
caus
least
two
follow
new
onset
purul
sputum
chang
charact
sputum
increas
respiratori
secret
increas
suction
requir
new
onset
worsen
cough
dyspnea
tachypnea
rale
bronchial
breath
sound
worsen
ga
exchang
eg
desatur
eg
pao
fio
increas
oxygen
requir
increas
ventil
demand
infant
year
old
two
serial
chest
radiograph
one
follow
new
progress
persist
infi
ltrate
consolid
cavit
pneumatocel
worsen
ga
exchang
eg
desatur
eg
pao
fio
increas
oxygen
requir
increas
ventil
demand
least
three
follow
temperatur
instabl
recogn
caus
leukopenia
wbcmm
leukocytosi
wbcmm
left
shift
band
form
new
onset
purul
sputum
chang
charact
sputum
increas
respiratori
secret
increas
suction
requir
apnea
tachypnea
nasal
fl
are
retract
chest
wall
grunt
new
onset
worsen
cough
dyspnea
tachypnea
wheez
rale
rhonchi
cough
bradycardia
beatsmin
tachycardia
beatsmin
box
fever
c
f
recogn
caus
leukopenia
wbcmm
leukocytosi
wbcmm
adult
year
old
alter
mental
statu
recogn
caus
least
one
follow
new
onset
purul
sputum
chang
charact
sputum
increas
respiratori
secret
increas
suction
requir
new
onset
worsen
cough
dyspnea
tachypnea
rale
bronchial
breath
sound
worsen
ga
exchang
eg
desatur
eg
pao
fio
increas
oxygen
requir
increas
ventil
demand
least
one
follow
posit
growth
blood
cultur
relat
anoth
sourc
infect
posit
growth
cultur
pleural
fl
uid
posit
quantit
cultur
minim
contamin
lower
respiratori
tract
specimen
eg
bronchoalveolar
lavag
protect
specimen
brush
bronchoalveolar
lavageobtain
cell
contain
intracellular
bacteria
direct
microscop
examin
eg
gram
stain
histopatholog
examin
show
least
one
follow
evid
pneumonia
abscess
format
foci
consolid
intens
neutrophil
accumul
bronchiol
alveoli
posit
quantit
cultur
lung
parenchyma
evid
lung
parenchyma
invas
fungal
hypha
pseudohypha
asymptomat
urinari
tract
infect
indwel
urinari
cathet
present
within
day
urin
cultur
patient
fever
c
urgenc
frequenc
dysuria
suprapub
tender
urin
cultur
organismsml
urin
two
speci
organ
indwel
urinari
cathet
present
within
day
fi
rst
two
urin
cultur
organismsml
urin
organ
two
speci
organ
patient
fever
c
urgenc
frequenc
dysuria
suprapub
tender
sinus
organ
isol
cultur
purul
materi
obtain
sinu
caviti
one
follow
fever
c
pain
tender
involv
sinu
headach
purul
exud
nasal
obstruct
either
follow
posit
transillumin
b
radiograph
evid
infect
gastroenter
acut
onset
diarrhea
liquid
stool
hour
without
vomit
fever
c
like
noninfecti
caus
eg
diagnost
test
therapeut
regimen
acut
exacerb
chronic
condit
psycholog
stress
two
follow
recogn
caus
nausea
vomit
abdomin
pain
headach
follow
enter
pathogen
isol
stool
cultur
rectal
swab
b
enter
pathogen
detect
routin
electron
microscopi
examin
c
enter
pathogen
detect
antigen
antibodi
assay
fece
blood
evid
enter
pathogen
detect
cytopath
chang
tissu
cultur
toxin
assay
e
diagnost
singl
antibodi
titer
igm
fourfold
increas
pair
serum
sampl
igg
pathogen
microbi
profi
le
infect
individu
site
icu
patient
shown
tabl
unrel
increas
nosocomi
infect
caus
intrins
resist
organ
past
decad
especi
coagulaseneg
staphylococci
aureu
enterococci
p
aeruginosa
resist
gramneg
bacilli
candida
moreov
incid
infect
caus
organ
acquir
resist
especi
methicillinresist
aureu
mrsa
enterococci
resist
vancomycin
vre
ampicillin
drug
gramneg
bacilli
resist
extendedspectrum
betalactam
fl
uoroquinolon
increas
even
sharpli
fig
nosocomi
infect
acquir
icu
clearli
differ
infect
acquir
nonicu
patient
care
unit
within
institut
overal
rate
intens
antimicrobi
therapi
characterist
modernday
icu
grossli
distort
patient
microfl
ora
moreov
half
nosocomi
epidem
occur
among
hospit
patient
confi
ned
icu
final
risk
occup
enterobacteriacea
pseudomona
aeruginosa
citrobact
speci
enterobact
speci
coagulaseneg
staphylococci
enterococci
candida
acinetobact
speci
klebsiella
pneumonia
two
three
time
higher
rate
ventilatorassoci
pneumonia
vap
primari
bacteremiamost
origin
intravascular
devicesar
time
higher
far
greater
proport
icuacquir
infect
caus
antibioticresist
bacteria
acquir
infect
among
health
care
worker
hcw
particularli
bloodborn
virus
herp
simplex
viru
hsv
highest
among
icu
personnel
contrast
work
nonicu
patient
care
unit
see
protect
health
care
worker
intens
care
unit
later
nosocomi
infect
consider
impact
morbid
mortal
estim
affect
million
patient
us
hospit
annual
tabl
summar
major
studi
examin
mortal
length
stay
cost
associ
major
nosocomi
infect
us
hospit
nosocomi
infect
ascrib
nation
institut
medicin
respons
hospit
death
year
result
billion
excess
health
care
cost
consid
nosocomi
infect
acquir
icu
patient
account
nearli
half
infect
hospit
progress
reduc
incid
infect
acquir
within
icu
could
produc
substanti
econom
benefi
ts
occurr
nosocomi
infect
refl
ect
conjunct
space
time
pathogen
microb
vulner
patient
catalyz
event
associ
hospit
patient
care
mani
patient
admit
icu
intrins
suscept
infect
underli
diseas
condit
associ
impair
immun
cancer
trauma
advanc
age
immunosuppress
associ
malnutrit
therapi
corticosteroid
cancer
chemotherapeut
agent
immunosuppress
drug
moreov
mani
drug
indirect
effect
increas
suscept
infect
narcot
sed
impair
capac
protect
airway
antacid
h
histamin
receptor
antagonist
neutral
gastric
acid
produc
gastric
overgrowth
gramneg
bacilli
increas
risk
nosocomi
pneumonia
even
transfus
therapi
produc
immunosuppress
increas
risk
nosocomi
infect
moreov
nosocomi
pathogen
exhibit
resist
antibiot
see
fig
mani
also
virul
capac
subsist
even
multipli
aqueou
reservoir
prolong
period
eg
pseudomonad
legionella
pneumophila
elabor
endotoxin
eg
gramneg
bacilli
exotoxin
p
aeruginosa
c
diffi
cile
aureu
product
adhes
exoglycocalyx
eg
coagulaseneg
staphylococci
confer
capac
adher
avidli
form
biofi
lm
biolog
prosthet
surfac
resist
host
defens
even
antibiot
patient
icu
receiv
broadspectrum
antibiot
resist
nosocomi
organ
enorm
ecolog
advantag
darwinian
fashion
predict
supplant
normal
cutan
respiratori
gastrointestin
fl
ora
case
colon
fi
rst
step
progress
nosocomi
infect
especi
patient
alreadi
vulner
underli
diseas
organ
virul
resist
antibiot
patient
invas
medic
devic
assist
invas
colon
organ
bypass
impair
host
defens
epidemiolog
infect
consist
reservoir
mode
mode
transmiss
pathogen
pathogen
factor
associ
increas
decreas
risk
infect
understand
epidemiolog
infect
essenti
develop
effect
strategi
prevent
icu
major
reservoir
nosocomi
organ
infect
colon
patient
fig
wherea
streptococcu
pneumonia
mycobacterium
tuberculosi
legionella
aspergillu
zygomycet
measl
rubella
infl
uenza
transmit
airborn
rout
best
evid
suggest
aerob
bacteriaparticularli
aureu
enterococci
enter
gramneg
bacilli
mani
virus
hepat
rsv
rotavirus
c
diffi
cile
even
candida
spread
icu
hand
medic
personnel
infect
even
perman
colon
surgeri
exposur
invas
devic
type
greatli
amplifi
transmiss
colon
suscept
infect
outbreak
aureu
group
streptococc
infect
usual
indic
health
care
provid
carrier
epidem
strain
airborn
spread
gramneg
bacilli
probabl
rare
unless
unusu
environment
circumst
gener
massiv
contamin
aerosol
increas
evid
suggest
mani
nosocomi
infect
acquir
icu
deriv
resist
organ
enter
origin
present
skin
lower
respiratori
tract
admiss
icu
explain
failur
convent
infect
control
practic
base
use
barrier
prevent
extrins
acquir
infect
wherea
food
even
enter
feed
prepar
often
heavili
contamin
microorgan
studi
conclus
link
contamin
diseas
nosocomi
organ
origin
colon
infect
patient
readili
perpetu
spread
contamin
medic
apparatu
devic
urinecollect
receptacl
respiratori
therapi
equip
transduc
use
hemodynam
monitor
dialysi
machin
fi
beropt
bronchoscop
endoscop
given
implicit
close
proxim
vulner
icu
patient
hcw
repeat
contact
day
almost
predict
icu
milieu
within
hospit
uniqu
conduc
epidem
infect
especi
infect
caus
antibioticresist
pathogen
although
success
immun
enhanc
could
theori
creat
protect
fi
nal
barrier
infect
nosocomi
organ
uniqu
featur
nosocomi
infectionenorm
microbi
heterogen
pervas
effect
invas
devic
procedur
often
larg
infect
inoculacan
overwhelm
healthiest
patient
immun
defens
measur
erad
reservoir
nosocomi
pathogen
block
transmiss
base
thorough
understand
epidemiolog
seem
much
like
protect
present
risk
factor
analysi
use
power
statist
techniqu
multivari
analysi
identifi
circumst
put
patient
increas
risk
nosocomi
infect
guid
develop
prevent
strategi
risk
factor
base
prospect
collect
data
case
use
multivari
analysi
list
tabl
urinari
tract
infect
pneumonia
postop
surgic
infect
intravascular
devicerel
bloodstream
infect
ventriculostomyassoci
mening
antibioticassoci
coliti
deep
candida
infect
critic
care
medicin
synonym
cuttingedg
hightech
medicin
mechan
ventilatori
support
hemodynam
monitor
total
parenter
nutrit
hemodialysi
intracrani
pressur
monitor
innov
form
surgeri
huge
arsen
drug
especi
antiinfect
everi
genr
technolog
anyth
els
forc
critic
care
medicin
accept
necess
nosocomi
infect
control
gener
invas
devic
type
far
import
determin
suscept
nosocomi
infect
underli
diseas
see
tabl
howev
view
welcom
news
far
hope
reduc
nosocomi
infect
come
decad
innov
improv
asept
techniqu
advanc
technolog
invas
devic
breakthrough
revers
ravag
chronic
organ
failur
degen
diseas
type
diabet
mellitu
begin
late
scatter
us
hospit
began
establish
infect
control
program
conduct
surveil
develop
infect
control
polici
especi
tri
implement
control
measur
consist
jcaho
ad
requir
hospit
accredit
establish
formal
infect
control
program
earli
cdc
undertook
determin
effect
nosocomi
infect
surveil
control
program
unit
state
auspic
studi
effi
caci
nosocomi
infect
control
senic
goal
senic
determin
extent
infect
control
program
adopt
us
hospit
ascertain
much
program
reduc
rate
nosocomi
infect
senic
launch
survey
us
hospit
determin
characterist
infect
control
program
complet
review
patient
medic
record
randomli
select
hospit
senic
found
hospit
reduc
nosocomi
infect
rate
approxim
surveil
hope
surveil
control
program
continu
evolv
prevent
nosocomi
infect
major
prioriti
us
public
health
servic
jcaho
institut
medicin
shift
prospectivepay
reimburs
hospit
power
fi
nancial
incent
reduc
rate
nosocomi
infect
anticip
effort
prevent
hospitalacquir
infect
assum
ever
greater
import
jcaho
mandat
hospit
activ
program
surveil
prevent
control
hospitalacquir
infect
begin
institut
infect
control
committe
represent
major
clinic
servic
hospit
depart
includ
institut
icu
essenti
member
infect
control
program
infect
control
practition
usual
regist
nurs
hospit
epidemiologist
usual
physician
train
infecti
diseas
microbiolog
implement
polici
develop
committe
educ
hospit
personnel
nosocomi
infect
control
investig
suspect
outbreak
box
surveil
nosocomi
infect
cornerston
effect
infect
control
program
offer
numer
potenti
benefi
ts
permit
determin
baselin
expect
infect
rate
assist
recognit
outbreak
evalu
new
polici
control
measur
identifi
es
institut
problem
requir
attent
permit
focus
infect
control
effort
educ
provid
reliabl
data
dissemin
individu
depart
increas
awar
involv
individu
staff
member
increas
visibl
infect
control
staff
patient
care
unit
provid
opportun
consult
ad
hoc
educ
facilit
earliest
discoveri
patient
communic
infect
permit
time
institut
isol
precaut
limit
spread
total
surveil
infect
labor
intens
hospit
focu
surveil
effort
infect
associ
high
morbid
eg
nosocomi
pneumonia
greatli
increas
health
care
cost
eg
postcardiac
surgeri
sternotomi
infect
caus
antibioticresist
organ
potenti
spread
eg
mrsa
c
diffi
cile
highli
prevent
eg
intravascular
devicerel
bloodstream
infect
character
major
effort
hospit
appli
numer
facet
health
care
principl
qualiti
improv
develop
industri
hospit
infect
control
program
work
qualiti
improv
year
infl
uenc
jcaho
probabl
heavili
focus
process
name
polici
procedur
rather
document
outcom
reduc
infect
rate
infect
control
program
us
hospit
close
alli
institut
qualiti
improv
depart
hospit
infect
control
program
also
regul
occup
safeti
health
administr
osha
term
institut
standard
program
protect
hcw
bloodborn
pathogen
tuberculosi
environment
protect
agenc
also
publish
regul
term
dispos
track
medic
wasteonli
small
fraction
truli
biohazard
final
essenti
health
care
personnel
work
icu
receiv
train
epidemiolog
control
nosocomi
infect
may
import
hous
offi
cer
teach
hospit
commonli
enter
icu
rudimentari
knowledg
asepsi
handson
contact
numer
patient
day
icu
physician
nurs
must
especi
familiar
hospit
guidelin
manag
invas
devic
particularli
intravascular
cathet
type
urinari
cathet
endotrach
tube
tracheostomi
moreov
physician
need
made
awar
broadspectrum
antimicrobi
therapi
greatli
increas
risk
superinfect
antibioticresist
bacteria
candida
well
antibioticassoci
coliti
caus
c
diffi
cile
accur
time
diagnost
microbiolog
essenti
nosocomi
infect
control
clinic
manag
patient
infect
although
mani
infect
diagnos
basi
clinic
criteria
alon
cultur
laboratori
test
allow
infect
diagnos
much
greater
certainti
certain
infect
bacteriuria
bacteremia
fungal
viral
infect
diagnos
without
cultur
laboratori
test
see
box
moreov
accur
antimicrobi
suscept
test
clinic
isol
mean
monitor
trend
antibiot
resist
hospit
organ
importantli
identifi
microbi
caus
nosocomi
infect
allow
epidemiolog
track
individu
pathogen
within
hospit
especi
commonli
spread
patient
patient
aureu
betahemolyt
streptococci
enterococci
numer
gramneg
bacilli
organiz
standpoint
institut
infect
control
program
clinic
microbiolog
laboratori
must
close
work
relationship
see
box
assist
surveil
must
strongli
laboratori
base
permit
detect
resolut
potenti
problem
laboratori
director
senior
member
laboratori
staff
perman
member
infect
control
committe
primari
role
clinic
microbiolog
laboratori
infect
control
program
provid
uptod
clinic
microbiolog
data
use
surveil
nosocomi
infect
identifi
cation
potenti
outbreak
protocol
develop
ensur
laboratori
staff
immedi
contact
infect
control
personnel
isol
certain
import
pathogen
mrsa
vancomycinresist
enterococci
vre
appear
new
resist
pattern
endem
organ
resist
klebsiella
speci
thirdgener
cephalosporin
p
aeruginosa
aminoglycosid
fl
uoroquinolon
carbapenem
sift
data
time
consum
develop
electron
inform
system
streamlin
process
essenti
improv
effi
cienci
infect
control
program
commerci
softwar
program
autom
process
avail
mani
program
automat
collat
microbiolog
data
provid
rudimentari
geograph
inform
perform
basic
statist
analys
assist
surveil
nosocomi
infect
identifi
cation
potenti
outbreak
report
cumul
summari
antimicrobi
suscept
data
antibiogram
anoth
essenti
respons
clinic
microbiolog
laboratori
implement
appropri
time
dissemin
antibiogram
help
guid
choic
empir
antimicrobi
pend
result
clinic
cultur
provid
valuabl
data
help
infect
control
depart
monitor
institut
antimicrobi
resist
trend
identifi
potenti
outbreak
clinic
laboratori
standard
instituteformerli
nation
committe
clinic
laboratori
standardsrecommend
institut
antibiogram
updat
least
annual
recent
publish
standard
content
format
autom
electron
system
collat
dissemin
nearli
realtim
antibiogram
along
antibioticus
decis
support
exist
implement
properli
effect
improv
antimicrobi
util
within
hospit
set
monitor
steril
spore
test
environment
sampl
advanc
microbiolog
support
epidemiolog
investig
addit
respons
expect
clinic
microbiolog
laboratori
although
univers
hospit
program
dedic
personnel
within
infect
control
program
perform
activ
clinic
microbiolog
laboratori
key
resourc
investig
suspect
outbreak
one
fi
rst
foremost
action
nosocomi
outbreak
suspect
immedi
retriev
avail
isol
put
epidem
pathogen
possibl
subtyp
need
move
rapidli
becom
appar
realiz
hospit
laboratori
discard
cultur
soon
isol
fulli
character
blood
isol
routin
save
least
year
laboratori
personnel
must
request
save
clinic
isol
unusu
organ
encount
fi
rst
time
cluster
organ
inform
infect
control
personnel
fi
nding
avail
isol
rapid
evolut
molecular
microbiolog
revolution
epidemiolog
investig
nosocomi
outbreak
molecularbas
test
rapid
diagnosi
bacteri
viral
fungal
infect
routin
avail
hospitalbas
refer
laboratori
modern
molecular
test
reliabl
detect
minut
number
organ
allow
direct
test
clinic
sampl
without
need
cultur
modernday
clinic
virolog
molecular
test
base
polymeras
chain
reaction
pcr
amplifi
cation
pathogen
dna
rna
supplant
tissu
cultur
allow
rapid
diagnosi
infect
would
otherwis
often
identifi
abl
classic
method
avail
molecular
subtyp
system
greatli
strengthen
investig
outbreak
well
research
epidemiolog
nosocomi
infect
antimicrobi
suscept
pattern
antibiogram
detail
biochem
profi
le
biotyp
often
use
initi
epidemiolog
subtyp
mani
bacteria
may
adequ
identifi
epidem
caus
unusu
pathogen
howev
epidem
organ
common
speci
aureu
diffi
cult
even
imposs
know
certainti
outbreak
deriv
common
sourc
use
techniqu
lack
suffi
cient
discriminatori
power
new
molecular
techniqu
subtyp
plasmid
profi
le
type
agaros
gel
electrophoresi
use
restrict
endonucleas
digest
pulsedfi
eld
electrophoresi
fig
dna
fi
ngerprint
avail
infect
control
research
laboratori
adapt
mani
hospit
laboratori
genet
probe
promis
even
power
tool
investig
outbreak
particularli
caus
antibioticresist
organ
although
molecularbas
test
offer
sever
advantag
tradit
microbiolog
techniqu
panacea
number
molecular
diagnost
assay
eg
analyt
specifi
c
reagent
asr
market
clinic
practic
requir
approv
us
food
drug
administr
absenc
publish
data
accuraci
precis
result
test
must
interpret
caution
alway
undergo
extens
inhous
valid
widespread
adopt
moreov
exquisit
sensit
mani
test
render
suscept
falseposit
result
consequ
environment
contamin
mandat
stringent
qualiti
control
practic
procedur
role
inanim
environ
transmiss
nosocomi
infect
subject
intens
debat
decad
shown
hospit
surfac
almost
univers
contamin
potenti
pathogen
bacteria
aureu
enterococcu
gramneg
bacilli
acinetobact
baumanii
prior
infect
control
personnel
routin
sampl
hospit
surfac
despit
level
surfac
colon
earli
studi
found
inanim
environmentsurfac
wall
even
airdo
contribut
materi
occurr
nosocomi
infect
invas
infect
caus
airborn
aspergillu
fi
lament
fungi
serious
immunocompromis
patient
although
inanim
surfac
may
rare
involv
direct
transmiss
infect
patient
recent
evid
suggest
surfac
may
well
play
import
role
nosocomi
acquisit
patho
isol
subject
endonucleas
digest
machin
endoscop
patient
three
center
use
olympu
autom
endoscop
washer
lane
univers
wisconsin
hospit
clinic
center
b
center
c
also
show
concord
institut
machin
endoscop
isol
patient
isol
lane
contain
unrel
control
strain
p
aeruginosa
use
molecular
subtyp
strongli
support
epidemiolog
studi
causal
implic
contamin
endoscop
washer
genesi
endoscopyassoci
nosocomi
p
aeruginosa
infect
us
center
use
fl
awe
washer
alvarado
cj
stolz
sm
maki
dg
nosocomi
infect
contamin
endoscop
fl
awe
autom
endoscop
washer
investig
use
molecular
epidemiolog
j
med
genic
bacteria
indirectli
contact
hcw
hand
equip
see
fig
indirect
rout
infect
particular
import
icu
patient
heavili
expos
invas
devic
high
risk
infect
icu
inanim
environ
may
becom
reservoir
transmiss
resist
nosocomi
organ
mrsa
c
diffi
cile
vre
gramneg
bacilli
klebsiella
spp
acinetobact
spp
enterobact
organ
studi
shown
enhanc
surfac
decontamin
hypochloritecontain
clean
solut
necessari
termin
outbreak
caus
c
diffi
cile
acinetobact
baumanii
although
icu
environ
made
microb
free
certain
organiz
architectur
environment
issu
must
address
design
remodel
icu
capac
systemat
improv
care
critic
ill
patient
prevent
nosocomi
infect
requir
structur
foundat
process
care
optim
ie
make
easi
hcw
right
diffi
cult
wrong
account
complianc
critic
polici
procedur
ongo
assess
outcom
need
built
administr
structur
icu
icu
must
adequ
staf
allow
process
care
carri
also
assur
high
level
complianc
essenti
infect
control
measur
hand
hygien
barrier
isol
adequ
staffi
ng
overemphas
numer
studi
found
greatli
increas
rate
nosocomi
infect
icu
staf
suboptim
staffi
ng
requir
met
temporari
personnel
unfamiliar
icu
infect
control
polici
procedur
larg
nosocomi
outbreak
enterobact
cloaca
infect
neonat
icu
harbarth
colleagu
found
infect
rate
period
understaffi
ng
strikingli
higher
period
adequ
level
staffi
ng
rr
ci
effect
understaffi
ng
like
multipl
howev
eros
basic
hygien
practic
excess
patienttostaff
ratio
like
explain
much
phenomenon
mani
publish
recommend
icu
architectur
design
empir
evid
reduc
rate
nosocomi
infect
larg
lack
although
research
necessari
specifi
c
featur
icu
design
achiev
level
evid
suffi
cient
evidencebas
guidelin
certain
facet
icu
layout
deserv
attent
icu
locat
area
limit
traffi
c
fl
ow
essenti
icu
personnel
icu
facil
design
icu
profession
mind
ensur
appropri
space
resourc
environ
daytoday
oper
recogn
grow
varieti
complex
life
support
equip
requir
care
mani
patient
cubicl
room
provid
minimum
per
bed
area
larg
enough
accommod
bed
equip
yet
allow
immedi
access
patient
time
side
bed
adequ
space
must
also
provid
storag
nurs
suppli
facil
dispos
biohazard
wast
eg
bedpan
fl
usher
clean
reprocess
storag
icu
equip
storag
housekeep
suppli
separ
patient
care
area
singlepati
room
may
increas
likelihood
handwash
done
improv
complianc
isol
practic
reduc
risk
crossinfect
exampl
mulin
colleagu
found
convert
open
unit
singl
room
icu
greatli
reduc
rate
patient
colon
baumanii
shirani
colleagu
found
renov
burn
unit
includ
separ
bed
enclosur
reduc
rate
nosocomi
infect
materi
use
fi
xture
furnitur
surfac
smooth
easi
clean
surfac
made
porou
materi
foster
bacteri
colon
adequ
number
sink
must
avail
conveni
handwash
icu
personnel
ideal
sink
locat
entranc
cubicl
patient
room
encourag
handwash
enter
personnel
contact
patient
immedi
environ
separ
sink
use
clean
reprocess
contamin
equip
sink
sink
drain
normal
contamin
pseudomonad
although
role
epidemiolog
nosocomi
infect
yet
unclear
howev
sink
design
minim
aerosol
format
splashback
icu
equip
one
class
isol
room
includ
anteroom
gown
handwash
necessari
modifi
cation
neg
pressur
roofl
ine
exhaust
permit
use
patient
tuberculosi
airborn
infect
chickenpox
measl
dissemin
hsv
infect
highli
contagi
emerg
pathogen
sever
acut
respiratori
syndrom
sar
human
coronaviru
icu
treat
bone
marrow
transplant
patient
patient
prolong
sever
granulocytopenia
positivepressur
isol
room
use
higheffi
cienci
particlearrest
hepa
fi
lter
avail
isol
room
patient
infect
transmit
respiratori
rout
protect
profoundli
granulocytopen
patient
must
kept
close
maintain
control
direct
airfl
ow
central
fi
ltere
airhandl
system
provid
least
six
roomexchang
per
hour
essenti
ideal
patient
room
capac
set
posit
neg
pressur
respect
rest
unit
room
maintain
perman
posit
pressur
varieti
microorgan
includ
bacteria
mycobacteria
fungi
parasit
isol
hospit
water
implic
endem
epidem
nosocomi
infect
mani
outbreak
caus
bacteria
typic
thought
water
organ
p
aeruginosa
stenotrophomona
maltophilia
baumanii
howev
import
epidemiolog
link
hospit
water
pathogen
legionella
group
nosocomi
legionellosi
fi
rst
describ
estim
case
legionellosi
acquir
health
care
set
mortal
rate
approach
contamin
hospit
potabl
water
remain
underappreci
despit
studi
show
legionella
speci
recov
hospit
water
system
number
studi
nosocomi
case
identifi
ed
specifi
c
diagnost
surveil
method
employ
characterist
hospit
water
system
associ
legionella
contamin
includ
pipe
system
deadend
facilit
stagnat
largevolum
water
heater
result
ineffi
cient
heat
hospit
water
sediment
buildup
water
heater
temperatur
c
tap
water
temperatur
c
maintain
water
ph
receiv
municip
water
untreat
monochloramin
despit
ubiqu
water
system
colon
legionella
speci
studi
demonstr
correl
level
colon
risk
infect
cdc
recommend
routin
surveil
hospit
water
system
although
stanc
controversi
research
pittsburgh
pennsylvania
allegheni
counti
health
depart
recommend
proactiv
stepwis
approach
involv
initi
surveil
hospit
water
legionella
contamin
regardless
presenc
absenc
institut
nosocomi
legionellosi
follow
continu
surveil
base
level
water
contamin
found
presenc
institut
legionellosi
legionella
speci
resist
chlorin
heat
make
challeng
erad
contamin
hospit
water
system
attempt
hyperchlorin
hospit
water
partial
success
chlorin
level
continu
maintain
part
per
million
time
produc
rapidli
acceler
corros
water
pipe
expens
thermal
erad
feasibl
use
heatandfl
ush
method
rais
water
tank
temperatur
greater
c
distal
water
site
c
short
period
time
although
effect
superh
labor
intens
constant
fear
patient
health
care
personnel
may
sustain
scald
injuri
wash
shower
tap
water
fl
ush
period
use
technolog
instantan
steam
heat
incom
water
ultraviolet
light
technic
feasibl
newer
hospit
water
system
may
incompat
older
hospit
water
system
perhap
attract
effect
safe
costeffi
cient
method
legionella
erad
may
use
continu
coppersilv
ioniz
system
steril
hospit
water
system
system
well
studi
past
decad
prove
highli
effect
reliabl
erad
legionella
contamin
hospit
water
importantli
elimin
nosocomi
legionellosi
institut
intervent
fail
institut
two
cluster
nosocomi
legionellosi
prompt
retrospect
review
identifi
ed
case
period
surveil
hospit
water
system
found
sampl
contain
low
level
l
pneumophila
shown
clonal
relat
case
nosocomi
legionellosi
instal
continu
coppersilv
ioniz
system
led
complet
erad
legionella
water
sampl
case
nosocomi
legionellosi
identifi
ed
institut
sinc
among
patient
hospit
reliabl
steril
disinfect
antisepsi
embrac
virtual
measur
aim
prevent
nosocomi
infect
critic
object
introduc
directli
bloodstream
normal
steril
area
bodi
surgic
instrument
cardiac
cathet
implant
devic
must
reliabl
steril
steril
steam
ga
hydrogen
peroxid
ga
chemic
steril
semicrit
item
come
contact
intact
mucou
membran
fi
beropt
endoscop
endotrach
tube
ventil
circuit
tube
decontamin
patient
pasteur
use
highlevel
chemic
disinfect
glutaraldehyd
peracet
acid
hydrogen
peroxid
ethyl
alcohol
hypochlorit
noncrit
item
normal
come
contact
intact
skin
blood
pressur
cuff
electrocardiograph
electrod
requir
hygien
cleans
lowlevel
disinfect
iodophor
hypochlorit
quaternari
ammonium
phenol
disinfect
alcohol
lone
except
classifi
cation
scheme
devic
pose
risk
transmit
prionrel
diseas
transmiss
spongiform
encephalopathi
creutzfeldtjakob
diseas
cjd
variant
cjd
vcjd
gain
consider
attent
past
decad
recent
address
publish
disinfect
steril
guidelin
prion
readili
inactiv
convent
disinfect
steril
procedur
result
devic
pose
risk
transmiss
prionrel
diseas
undergo
special
steril
procedur
clean
involv
sodium
hydroxid
follow
lowtemperatur
autoclav
c
hightemperatur
autoclav
c
hour
c
minut
despit
concern
procedur
involv
semicrit
item
endoscop
bronchoscop
may
pose
risk
transmiss
prionrel
infect
singl
report
cjd
vcjd
associ
devic
result
current
guidelin
recommend
critic
item
semicrit
item
come
contact
neurolog
tissu
eg
brain
spinal
cord
eye
tissu
undergo
special
prion
inactiv
steril
procedur
numer
epidem
gramneg
infect
describ
associ
respiratori
therapi
equip
diagnost
equip
bronchoscop
endoscop
solut
use
cutan
antisepsi
outbreak
trace
improp
procedur
malfunct
autom
system
use
disinfect
steril
medic
devic
although
number
epidem
year
past
aros
result
extrins
contamin
solut
use
cutan
antisepsi
reason
import
strict
adher
recommend
polici
procedur
clean
reprocess
medic
equip
use
icu
overemphas
endoscop
bronchoscop
essenti
diagnost
therapeut
instrument
icu
although
postendoscopi
nosocomi
infect
caus
inocul
colon
mucos
fl
ora
normal
steril
vulner
anatom
site
procedur
numer
epidem
trace
contamin
endoscop
follow
use
bronchoscopi
endoscop
typic
contamin
colonyform
unit
cfusml
endoscop
consid
semicrit
medic
devic
spauld
classifi
cation
therefor
requir
highlevel
disinfect
follow
use
order
ensur
safe
use
fl
exibl
endoscop
reprocess
follow
procedur
physic
clean
reduc
microbi
bioburden
remov
organ
debri
highlevel
disinfectionglutaraldehyd
autom
chemic
steril
system
use
peracet
acid
commonli
use
unit
stateswith
adequ
contact
time
disinfect
devic
surfac
follow
disinfect
rins
steril
fi
ltere
tap
water
remov
disinfect
residu
fl
ush
channel
ethyl
isopropyl
alcohol
dri
forc
air
devic
use
endoscop
violat
mucos
barrier
biopsi
forcep
need
reprocess
critic
medic
item
full
steril
devic
use
deliveri
respiratori
care
also
consid
semicrit
spauld
classif
therefor
reprocess
manner
similar
endoscop
prior
reus
iodophor
eg
povidoneiodin
recent
common
agent
use
cutan
disinfect
north
america
howev
larg
prospect
random
trial
cutan
antisept
use
draw
blood
cultur
recent
show
chlorhexidin
superior
povidoneiodin
associ
twofold
reduc
rate
contamin
blood
cultur
ci
p
moreov
recent
metaanalysi
examin
impact
differ
cutan
antisept
agent
found
chlorhexidin
superior
povidoneiodin
prevent
intravascular
cathet
colon
catheterrel
bloodstream
infect
basi
recent
studi
chlorhexidinecontain
solut
prefer
cutan
antisept
insert
intravascular
devic
icu
whatev
agent
use
essenti
appli
vigor
scrub
minimum
minut
allow
adequ
time
germicid
activ
major
reservoir
nosocomi
infect
icu
infect
colon
patient
major
mode
spread
nosocomi
bacteri
pathogen
mani
virus
even
candida
patient
patient
transient
carriag
hand
medic
personnel
see
fig
studi
center
hand
carriag
nosocomi
pathogen
icu
personnel
use
simpl
rins
techniqu
quantifi
transient
fl
ora
shown
averag
approxim
cfu
log
recov
hand
icu
personnel
randomli
sampl
tabl
nearli
half
person
cultur
point
time
found
carri
gramneg
bacilli
carri
aureu
serial
cultur
shown
icu
personnel
variou
time
carri
gramneg
bacilli
nearli
two
third
carri
aureu
carriag
gramneg
bacilli
aureu
typic
transient
sampl
person
everi
day
prolong
period
shown
aureu
gramneg
speci
consecut
cultur
time
prolong
carriag
singl
gramneg
speci
seem
rarebut
report
hygien
handwash
undertak
invas
procedur
handl
open
wound
manual
contact
highrisk
patient
eg
newborn
patient
icu
touch
sourc
object
like
contamin
recogn
sinc
time
semmelwei
lister
one
basic
import
infect
control
measur
despit
univers
acknowledg
handwash
cornerston
nosocomi
infect
control
program
complianc
rate
much
diffi
cult
achiev
handwash
rate
among
hcw
rang
numer
observ
studi
recent
investig
undertaken
better
understand
reason
poor
complianc
face
compel
evid
hand
hygien
essenti
prevent
nosocomi
infect
identifi
cutan
irrit
inconveni
sink
locat
time
constraint
high
workload
understaffi
ng
concern
risk
factor
noncompli
hand
hygien
includ
physician
rather
nurs
work
icu
paradox
engag
patientcar
activ
high
risk
crosstransmiss
intervent
redress
defi
cienci
includ
target
educ
feedback
conveni
locat
sink
hand
hygien
agent
use
altern
less
irrit
hand
hygien
agent
hand
care
lotion
cream
patient
educ
studi
done
work
hospit
staff
shown
hygien
handwash
antisepticcontain
agent
reduc
count
microorgan
hand
user
far
effect
handwash
nonmed
soap
repeat
use
antisept
chlorhexidin
cumul
suppress
effect
transient
hand
fl
ora
routin
use
antisepticcontain
handwash
agent
could
theori
enhanc
effect
handwash
done
moreov
agent
exhibit
prolong
antimicrobi
activ
chlorhexidin
use
might
also
confer
protect
contamin
acquir
handwash
howev
antisepticcontain
handwash
agent
expens
often
irrit
skin
irrit
result
dermat
paradox
increas
colon
gramneg
bacilli
clearli
antisepticcontain
soap
effect
remov
microorgan
hand
user
routin
use
agent
hygien
handwash
reduc
incid
nosocomi
infect
patient
discontinu
hexachlorophen
handwash
personnel
bath
infant
unit
state
follow
mark
upsurg
aureu
infect
nurseri
use
chlorhexidinecontain
handwash
agent
consid
essenti
measur
control
hospit
outbreak
caus
multipli
resist
klebsiella
mrsa
howev
sinc
semmelwei
studi
studi
prospect
evalu
effi
caci
antisepticcontain
handwash
agent
reduc
endem
nosocomi
infect
particularli
infect
caus
gramneg
bacilli
compar
sequenti
trial
three
handwash
agentsa
nonmed
tissu
soap
povidoneiodin
betadin
scrub
chlorhexidin
hibiclen
undertaken
traumasurg
icu
univers
wisconsin
hospit
agent
use
exclus
approxim
week
time
hand
cultur
icu
personnel
done
random
surveil
infect
patient
carri
risk
factor
infect
patient
hospit
use
agent
compar
nearli
two
third
patient
period
requir
ventilatori
support
hemodynam
monitor
almost
urinari
cathet
incid
nosocomi
infect
group
expectedli
high
lower
use
two
antisepticcontain
handwash
agent
use
nonmed
soap
p
povidoneiodin
irrit
hand
staff
chlorhexidin
slightli
dri
effect
well
toler
compar
nonmed
soap
similar
studi
univers
iowa
hospit
massanari
heirholz
fi
nd
signifi
cant
differ
rate
nosocomi
infect
nonmed
soap
use
exclus
compar
altern
cycl
chlorhexidin
hibiclen
use
surgic
icu
howev
incid
infect
medic
icu
lower
use
chlorhexidin
p
largest
multiplecrossov
prospect
adult
patient
three
icusof
rel
effi
caci
antisepticcontain
handwash
agent
use
personnel
icu
doebbel
colleagu
found
use
chlorhexidin
hibiclen
associ
reduct
nosocomi
infect
contrast
rate
alcohol
handrins
agent
calstat
use
regimen
well
toler
recent
alcoholbas
waterless
hand
rub
becom
agent
choic
hand
hygien
univers
use
us
hospit
conveni
broadspectrum
activ
alcohol
rapid
pronounc
bactericid
action
greatli
reduc
time
need
hand
disinfect
vigor
rub
suffi
cient
volum
alcohol
wet
hand
complet
shown
highli
effect
reduc
densiti
skin
fl
ora
ethanol
isoand
npropanol
constitu
commerci
avail
alcoholbas
hand
rub
equal
concentr
npropanol
effect
ethanol
least
howev
limit
effi
caci
gross
soilag
visibl
soil
hand
alway
wash
antisept
soap
water
moreov
least
ml
alcoholbas
rub
necessari
complet
coat
hand
achiev
optim
degerm
use
alcohol
hand
rub
gel
augment
make
conveni
locat
calibr
dispens
wide
avail
howev
mani
hcw
prefer
individu
contain
carri
pocket
make
diffi
cult
ensur
adequ
volum
use
applic
trial
conduct
evalu
effi
caci
alcoholcontain
hand
rub
reduc
nosocomi
infect
quasiexperiment
beforeaft
studi
shown
shortterm
reduct
nosocomi
infect
rate
use
alcoholcontain
hand
rub
major
factor
limit
accept
alcohol
product
hand
antisepsi
past
desicc
irrit
skin
obviat
incorpor
emolli
alcoholbas
hand
rub
enhanc
accept
hcw
may
augment
antibacteri
activ
slow
evapor
alcohol
recent
random
clinic
trial
icu
hcw
compar
convent
chlorhexidin
glucon
wash
water
waterless
alcoholbas
hand
rub
ethanol
emolli
show
use
waterless
alcoholbas
product
produc
signifi
cantli
less
skin
scale
irrit
unfortun
degerm
assess
recent
review
describ
detail
variou
hand
hygien
agent
avail
spectrum
activ
recommend
hand
hygien
cdc
recent
publish
tabl
emphas
hand
antisepsi
antisepticcontain
soap
deterg
alcoholbas
hand
rub
direct
contact
patient
environ
equip
immedi
vicin
patient
perform
invas
procedur
insert
intravascular
devic
urinari
cathet
use
skin
care
productslot
creamsto
minim
irrit
contact
dermat
associ
frequent
handwash
improv
complianc
hand
hygien
practic
highli
recommend
institut
commit
essenti
improv
complianc
recommend
hand
hygien
practic
cdc
guidelin
recommend
institut
monitor
record
adher
hand
hygien
ward
servic
provid
feedback
hcw
perform
monitor
volum
alcohol
hand
rub
use
per
patientday
clearli
studi
necessari
particularli
larg
compar
trial
rate
nosocomi
infect
rather
level
cutan
colon
use
index
comparison
meantim
avail
data
indic
routin
use
chlorhexidinecontain
product
alcoholcontain
product
effect
use
nonmed
soap
hand
hygien
highrisk
area
hospit
icu
crossinfect
like
occur
isol
use
special
precaut
care
infect
patient
mean
curtail
spread
contagi
microorgan
prevent
epidem
especi
icu
risk
crossinfect
highest
although
requir
person
enter
infect
patient
room
wear
glove
gown
possibl
even
mask
may
seem
ritualist
almost
archaic
aspect
isol
procedur
direct
interrupt
potenti
mode
spread
base
known
epidemiolog
infect
organ
maxim
effect
howev
isol
procedur
requir
complianc
person
come
contact
patient
includ
physician
isol
also
indic
usual
entireti
hospit
patient
infect
known
colon
antibioticresist
nosocomi
pathogen
mrsa
gramnega
tive
bacilli
resist
aminoglycosid
thirdgener
cephalosporin
vre
case
isol
shown
effect
reduc
endem
infect
fig
control
outbreak
isol
system
us
hospit
subscrib
one
two
cdc
isol
system
develop
panel
expert
simplest
system
categoryspecifi
c
isol
precaut
issu
cdc
group
diseas
seven
categori
infect
similar
precaut
indic
wound
skin
precaut
enter
precaut
discharg
precaut
blood
precaut
respir
isol
strict
isol
protect
isol
guidelin
diseasespecifi
c
isol
precaut
issu
consid
infecti
diseas
individu
precaut
indic
interrupt
transmiss
specifi
c
diseas
use
diseasespecifi
c
precaut
minim
unnecessari
isol
procedur
howev
complic
may
implement
effect
computer
system
altern
simpler
system
bodi
substanc
isol
gain
adher
focus
isol
potenti
infecti
bodi
substanc
blood
fece
urin
sputum
wound
drainag
bodi
fl
uid
patient
use
simpl
barrier
precautionsprimarili
glove
gown
plastic
apron
mask
goggl
barrier
use
potenti
infecti
secret
like
soil
splash
cloth
skin
face
hcw
bodi
substanc
isol
provid
suffi
cient
fl
exibl
augment
basic
precaut
taken
patient
need
add
privat
room
mask
infect
transmit
airborn
rout
critic
simpler
system
reduc
emphasi
handwash
glove
remov
recent
cdc
guidelin
current
draft
form
separ
basic
precaut
standard
precaut
design
care
patient
hospit
regardless
diagnosi
presum
infect
statu
addit
transmissionbas
precaut
design
care
specifi
ed
patient
known
suspect
infect
highli
transmiss
epidemiolog
import
pathogen
standard
precaut
synthes
major
featur
univers
blood
bodi
fl
uid
precaut
design
reduc
risk
transmiss
microorgan
patient
patient
patient
hcw
recogn
unrecogn
sourc
infect
hospit
transmissionbas
precaut
divid
three
subgroup
basi
mode
transmiss
contact
precaut
droplet
precaut
airborn
precaut
contact
precaut
recommend
multidrugresist
bacteria
acquir
contact
colon
patient
environment
surfac
object
droplet
precaut
provid
addit
measur
transmiss
largeparticl
droplet
suction
bronchoscopi
airborn
precaut
ad
standard
precaut
care
patient
tuberculosi
microorgan
transmit
airborn
rout
gener
transmissionbas
precaut
usual
specifi
privat
roomalway
airborn
precaut
environment
issu
pertain
isol
may
relev
icu
name
greater
potenti
fomit
environment
surfac
contribut
spread
nosocomi
infect
especi
antibioticresist
microorgan
although
previou
studi
abl
demonstr
inanim
hospit
environ
particularli
surfac
wall
fl
oor
contribut
materi
occurr
nosocomi
infect
accumul
evid
suggest
may
necessarili
true
icu
uniform
exposur
invas
devic
make
patient
unduli
suscept
number
care
studi
epidemiolog
icuacquir
infect
resist
organ
mrsa
c
diffi
cile
vre
shown
heavi
contamin
inanim
environ
immedi
contigu
patient
strain
implic
nosocomi
infect
occur
patient
even
glove
worn
part
protect
isol
univers
precaut
possibl
transmiss
microorgan
environ
patient
glove
hand
hcw
real
prolong
wear
glove
icu
common
may
increas
risk
nosocomi
crossinfect
expand
epidemiolog
role
inanim
environ
certain
pathogen
mrsa
vre
similarli
use
common
stethoscop
sphygmomanomet
electron
thermomet
multipl
patient
provid
opportun
organ
spread
although
stethoscop
commonli
contamin
nosocomi
organ
role
crossinfect
less
clear
hand
spread
vre
c
diffi
cile
trace
contamin
electron
thermomet
surfac
contigu
icu
patient
wipe
gener
hospit
disinfect
least
daili
icu
patient
dedic
stethoscop
sphygmomanomet
use
electron
temperatur
measur
devic
multipl
patient
within
icu
bear
reevalu
unless
stringent
effort
made
assur
reliabl
decontamin
devic
use
discuss
mani
nosocomi
infect
appear
deriv
organ
carri
hand
icu
personnel
work
day
contact
multipl
patient
improv
nurs
care
reduc
risk
crossinfect
icu
must
adequ
number
staff
although
optim
nursepati
ratio
patient
icu
known
increas
rate
infect
outbreak
occur
nurs
assign
multipl
critic
ill
patient
requir
complic
nurs
care
onetoon
nurs
patient
ratio
may
signifi
cantli
reduc
risk
crossinfect
contain
spread
certain
resist
organ
icu
eg
mrsa
vre
cohort
nurs
strongli
recommend
cohort
nurs
care
patient
known
infect
colon
organ
provid
nurs
respiratori
therapist
provid
care
shift
noninfect
patient
nurs
care
noninfect
patient
restrict
personnel
contact
infect
patient
except
emerg
cohort
patient
known
colon
infect
mrsa
wide
practic
adequ
studi
one
recent
prospect
studi
author
found
evid
increas
transmiss
mrsa
patient
cohort
upsurg
tuberculosi
sinc
particularli
numer
nosocomi
outbreak
caus
multidrugresist
strain
demonstr
import
isol
precaut
prevent
spread
tuberculosi
within
hospit
especi
within
icu
new
guidelin
reemphas
import
air
control
mandat
use
privat
negativepressur
room
combin
use
ultraviolet
light
ventilatori
modifi
cation
air
exit
room
either
fi
ltere
exhaust
directli
roofl
ine
away
hospit
intak
vent
isol
room
door
must
kept
close
maintain
control
direct
airfl
ow
person
enter
room
tuberculosi
isol
precaut
effect
must
wear
dispos
particul
respir
dustmist
mask
hepafi
lter
mask
gown
glove
usual
indic
icu
one
negativepressur
isol
room
care
patient
requir
respiratori
isol
tuberculosi
airborn
infect
chickenpox
dissemin
herp
zoster
dissemin
hsv
infect
emerg
highli
contagi
airborn
infect
sar
reduc
risk
contamin
ventil
discharg
tuberculosi
environ
mechan
ventil
patient
suspect
confi
rmed
pulmonari
tuberculosi
bacteri
fi
lter
capabl
fi
ltere
particl
size
fi
lter
effi
caci
greater
place
patient
endotrach
tube
expiratori
side
breath
circuit
ventil
icu
patient
tuberculosi
requir
mechan
ventil
wear
surgic
mask
leav
negativepressur
isol
room
radiograph
procedur
world
epidem
aid
evid
million
person
unit
state
silent
carrier
human
immunodefi
cienci
viru
hiv
engend
great
concern
among
hcw
regard
risk
exposur
hiv
workplac
cdc
depart
labor
issu
detail
guidelin
univers
blood
bodi
fluid
precaut
prevent
exposur
hcw
worker
patient
potenti
hazard
blood
bodi
fl
uid
univers
precaut
base
concept
blood
bodi
fl
uid
might
contamin
blood
treat
infecti
patient
bloodborn
infect
asymptomat
unawar
infect
relev
univers
precaut
aspect
diseas
transmiss
recogn
cdc
expand
concept
chang
term
standard
precaut
standard
precaut
integr
expand
element
univers
precaut
standard
care
design
protect
health
care
personnel
patient
pathogen
spread
blood
bodi
fl
uid
excret
secret
standard
precaut
appli
contact
blood
bodi
fl
uid
secret
excret
except
sweat
regardless
whether
contain
blood
nonintact
skin
mucou
membran
glove
recommend
venipunctur
insert
intravascular
devic
whenev
anticip
hand
could
becom
contamin
blood
anoth
highrisk
bodi
fl
uid
potenti
splatter
contamin
cloth
gown
ad
potenti
aerosol
bodi
fl
uid
surgeri
intub
endoscopi
insert
arteri
cathet
mask
eye
shield
includ
vast
major
occup
relat
hiv
infect
involv
needl
stick
sharp
injuri
everi
effort
must
made
avert
injuri
could
result
percutan
inocul
hiv
bloodborn
virus
prophylact
use
barrier
precaut
appear
benefi
prevent
nosocomi
infect
us
hospit
current
mandat
follow
standard
precaut
suggest
use
glove
patient
contact
common
mani
us
hospit
implicitli
reduc
risk
nosocomi
infect
gener
howev
demonstr
concern
standard
precaut
might
paradox
increas
risk
nosocomi
crossinfect
us
hospit
still
common
observ
icu
personnel
mani
routin
wear
glove
patient
contact
protect
put
glove
touch
heavili
contamin
area
eg
open
wound
tracheostomi
without
remov
glove
proceed
write
patient
chart
answer
telephon
care
anoth
patient
occur
health
care
provid
forgotten
although
glove
may
protect
glove
must
immedi
discard
use
prevent
crosscontamin
hazard
pathogen
vulner
site
patient
transmiss
patient
icu
environ
era
aid
univers
precaut
health
care
profession
orient
toward
protect
patient
like
wash
hand
expos
potenti
contamin
focu
centripet
mani
hcw
unfortun
view
precaut
measur
protect
thu
prolong
wear
glove
result
heavi
contamin
glove
increas
risk
nosocomi
crossinfect
among
patient
also
put
hcw
worker
increas
risk
dermat
allerg
reaction
glove
materi
standard
precaut
obviat
need
design
isol
precaut
patient
communic
infect
greatli
expand
use
glove
part
standard
precaut
hospit
must
accompani
educ
program
use
glove
effect
manner
jeopard
patient
staff
must
strongli
encourag
wash
hand
remov
glove
especi
perform
bloodi
procedur
blood
often
penetr
defect
glove
found
hand
wearer
moreov
glove
hcw
handson
contact
patient
colon
mrsa
vre
process
remov
glove
result
contamin
hand
hcw
organ
one
third
time
world
crisi
antibiot
resist
fig
refl
ect
greatest
measur
heavi
use
system
antibiot
worldwid
past
year
especi
hospit
antimicrobi
therapi
greatest
ecolog
impact
close
confi
ne
icu
nosocomi
outbreak
caus
antibioticresist
microorgan
occur
patient
hospit
icu
antibiot
pressur
promot
exchang
gene
encod
drug
resist
varieti
transfer
mechan
fig
shown
singl
import
factor
predispos
patient
nosocomi
infect
resist
organ
modernday
icu
breed
ground
multipli
resist
bacteria
encount
hospit
throughout
world
methicillinresist
staphylococci
vre
enterobact
serratia
citrobact
proteusprovidencia
p
aeruginosa
resist
fl
uoroquinolon
aminoglycosid
extendedspectrum
betalactam
broadspectrum
antimicrobi
therapi
root
caus
antibioticassoci
diarrhea
coliti
caus
c
diffi
cile
clearli
antimicrobi
wide
overus
misus
patient
us
icu
coronari
care
unit
receiv
antimicrobi
agent
wherea
studi
indic
half
hospit
patient
receiv
antimicrobi
therapi
evid
infect
clear
justifi
cation
receiv
antibiot
moreov
within
icu
high
proport
antibiot
use
broadspectrumextendedspectrum
penicillin
thirdgener
cephalosporin
carbapenem
aminoglycosid
fl
uoroquinolon
greater
effort
must
direct
improv
use
system
antibiot
especi
within
icu
jcaho
mandat
hospit
period
review
use
antimicrobi
agent
use
antimicrobi
audit
audit
scrutin
need
antimicrobi
therapyclear
evid
infect
clear
justifi
cation
prophylact
use
appropri
regimen
select
monitor
therapeut
effi
caci
side
effect
therapi
educ
program
institut
guidelin
antimicrobi
use
permit
hospit
staff
construct
guidelin
polici
base
local
need
judgment
aid
publish
criteria
shown
materi
improv
antimicrobi
use
within
hospit
import
method
control
antimicrobi
use
includ
restrict
formulari
polici
clinic
microbiolog
laboratori
report
suscept
test
automat
stop
order
surgic
prophylaxi
mani
institut
also
place
expens
broadspectrum
drug
eg
thirdgener
cephalosporin
carbapenem
amikacin
ciprofl
oxacin
fl
uconazol
ganciclovir
lipidassoci
amphotericin
b
restrict
list
requir
physician
wish
use
agent
justifi
use
repres
institut
antibiot
review
committe
program
greatli
reduc
use
restrict
antibiot
gain
everwid
accept
excel
resourc
includ
chapter
book
chapter
avail
guid
select
use
antiinfect
drug
critic
ill
patient
howev
sever
principl
reduc
unnecessari
antimicrobi
therapi
improv
use
drug
given
cultur
appropri
diagnost
test
indic
done
without
fail
begin
antimicrobi
therapi
treatment
presum
infect
icu
patient
whenev
antimicrobi
therapi
begun
reason
document
patient
record
eg
treatment
pneumonia
surgic
prophylaxi
possibl
singl
drug
narrowspectrum
drug
drug
use
especi
infect
organ
organ
known
outset
need
continu
antimicrobi
therapi
reassess
daili
cultur
identifi
infect
microorgan
microorgan
therapi
modifi
ed
aim
narrowspectrum
drug
drug
like
effect
diagnost
studi
neg
hour
patient
exhibit
sign
sepsi
antibiot
therapi
discontinu
unless
patient
profoundli
granulocytopen
beyond
monitor
effi
caci
advers
drug
effect
hypersensit
organ
toxic
essenti
monitor
includ
surveil
superinfect
resist
bacteria
candida
c
diffi
cile
diarrhea
surgic
antimicrobi
prophylaxi
extend
beyond
hour
postop
oper
limit
singl
dose
note
earlier
nosocomi
infect
especi
immunolog
compet
patient
icu
causal
relat
surgic
oper
exposur
invas
devic
variou
type
see
tabl
comprehens
guidelin
prevent
infect
procedur
devic
pose
greatest
risk
urinari
cathet
endotrach
intub
mechan
ventilatori
support
intravascular
cathet
infus
therapi
hemodialysi
surgeri
publish
form
basi
institut
polici
procedur
health
care
profession
work
icu
oblig
inform
prevent
infect
associ
procedur
perform
devic
work
daili
obtain
maintain
reliabl
vascular
access
becom
one
essenti
featur
modernday
intens
care
unfortun
vascular
access
associ
substanti
gener
underappreci
potenti
produc
iatrogen
diseas
particularli
bloodstream
infect
bsi
origin
infect
percutan
intravascular
devic
ivd
use
vascular
accessivdrel
ivdr
bsi
often
refer
line
sepsi
nearli
nosocomi
bacteremia
deriv
vascular
access
form
estim
ivdrel
bloodstream
infect
occur
unit
state
year
studi
perform
decad
ago
found
ivdrel
bsi
associ
excess
attribut
mortal
rang
howev
recent
casecontrol
studi
consist
found
excess
mortal
especi
magnitud
controversi
asid
studi
examin
impact
ivdrel
bsi
patient
outcom
found
ivdrel
bsi
associ
increas
length
hospit
excess
health
care
cost
averag
per
case
ivdrel
bsi
larg
prevent
goal
must
simpli
identifi
treat
infect
rather
prevent
past
decad
much
learn
pathogenesi
epidemiolog
infect
associ
ivd
draw
exist
knowledg
pathogenesi
epidemiolog
ivdrel
bsi
ration
effect
guidelin
prevent
formul
ivd
associ
local
system
infect
cdc
publish
defi
nition
ivdrel
infect
see
box
defi
nition
use
purpos
surveil
reli
heavili
construct
central
venou
catheterassoci
bsi
implicitli
assum
primari
bsi
ie
bsi
without
identifi
abl
local
infect
origin
central
venou
cathet
cvc
practic
result
overestim
true
risk
cvcrelat
infect
primari
bsi
origin
central
venou
devic
secondari
bsi
deriv
unrecogn
postop
surgic
site
intraabdomin
infect
nosocomi
pneumonia
origin
vascular
devic
peripher
venou
cathet
arteri
cathet
use
hemodynam
monitor
appli
molecular
subtyp
techniqu
result
semiquantit
quantit
cultur
remov
ivd
blood
cultur
result
cultur
blood
drawn
ivd
separ
concomit
percutan
peripher
blood
cultur
possibl
reliabl
determin
whether
ivd
sourc
nosocomi
bsi
use
new
diagnost
techniqu
allow
formul
simpl
rigor
defi
nition
ivdrel
infect
tabl
believ
bear
consider
standard
random
trial
epidemiolog
studi
ivdrel
infect
recent
evidencebas
guidelin
provid
best
current
inform
evalu
icu
patient
fever
sign
sepsi
decis
regard
initi
antimicrobi
therapi
remov
ivd
patient
must
thoroughli
examin
identifi
plausibl
site
infect
includ
vap
catheterassoci
urinari
tract
infect
surgic
site
infect
antibioticassoci
coliti
line
sepsi
despit
challeng
identifi
sourc
patient
sign
sepsi
sever
clinic
epidemiolog
microbiolog
fi
nding
point
strongli
toward
ivd
sourc
septic
episod
tabl
patient
abrupt
onset
sign
symptom
sepsi
without
identifi
abl
local
infect
pneumonia
surgic
site
infect
prompt
suspicion
infect
ivd
presenc
infl
ammat
purul
cathet
insert
site
uncommon
patient
ivdrel
bsi
howev
infl
ammat
especi
purul
seen
combin
sign
symptom
sepsi
highli
like
patient
ivdrel
bsi
prompt
remov
devic
final
recoveri
certain
microorgan
multipl
blood
cultur
staphylococci
corynebacterium
bacillu
speci
candida
malassezia
strongli
suggest
infect
ivd
start
antiinfect
drug
suspect
presum
infect
critic
ill
patient
without
fi
rst
obtain
blood
cultur
two
separ
site
least
one
drawn
peripher
vein
percutan
venipunctur
indefens
volum
blood
cultur
essenti
maxim
sensit
blood
cultur
diagnosi
bacteremia
candidemia
adult
obtain
least
ml
ideal
ml
per
draw
specimen
contain
ml
ml
inocul
aerob
anaerob
media
signifi
cantli
improv
yield
compar
obtain
ml
draw
cultur
smaller
total
volum
adult
least
ml
blood
cultur
detect
bacteremia
identifi
ed
similar
oper
characterist
achiev
pediatr
popul
use
weightbas
graduat
volum
approach
blood
cultur
standard
blood
cultur
drawn
cvc
provid
excel
sensit
diagnosi
bsi
less
specifi
c
cultur
obtain
peripher
vein
patient
longterm
multilumen
cathet
may
reason
obtain
specimen
lumen
cathet
studi
found
discord
among
cultur
obtain
differ
lumen
cathet
everi
effort
must
made
prevent
introduc
contamin
draw
blood
cultur
singl
contamin
blood
cultur
shown
prolong
hospit
day
increas
cost
hospit
tinctur
iodin
isopropyl
alcohol
chlorhexidin
povidoneiodin
combin
alcohol
rather
povidoneiodin
alon
use
skin
antisepsi
prior
venipunctur
blood
cultur
recogn
studi
shown
signifi
cantli
reduc
rate
contamin
use
agent
blood
cultur
posit
coagulaseneg
staphylococcu
cn
repres
true
infect
howev
major
singl
posit
cultur
repres
contamin
fi
nding
reemphas
need
obtain
cultur
two
separ
site
whenev
bsi
suspect
remov
direct
cultur
ivd
histor
gold
standard
confi
rming
presenc
ivdrel
bsi
particularli
shortterm
ivd
studi
shown
cultur
cathet
segment
semiquantit
solid
media
quantit
liquid
media
eg
remov
adher
organ
sonic
provid
superior
sensit
specifi
citi
diagnosi
ivdrel
bsi
strong
correl
high
coloni
count
line
sepsi
growth
greater
equal
cfu
cathet
segment
semiquantit
cultur
growth
greater
equal
cfu
cathet
cultur
sonic
accompani
local
infl
ammat
sign
sepsi
indic
local
cathet
infect
signifi
cant
growth
absenc
local
system
infl
ammat
suggest
colon
devic
continu
vascular
access
necessari
new
devic
place
new
locat
rather
replac
new
one
locat
guidewir
exchang
although
recent
studi
suggest
quantit
method
eg
sonic
superior
semiquantit
method
eg
roll
plate
studi
shown
equival
hub
contamin
progress
intralumin
colon
primari
rout
infect
longterm
devic
eg
devic
place
day
quantit
techniqu
may
superior
semiquantit
techniqu
detect
infect
type
devic
remov
organ
intern
extern
surfac
cathet
contrast
semiquantit
method
may
prefer
quantit
method
case
suspect
infect
relat
shortterm
devic
eg
devic
place
day
primari
rout
infect
set
caus
extralumin
ingress
skin
organ
cathet
insert
site
semiquantit
method
simpl
less
expens
allow
identifi
cation
infect
organ
day
earlier
direct
impress
gram
stain
acridin
orang
stain
intravascular
segment
remov
cathet
shown
excel
correl
quantit
techniqu
cultur
cathet
permit
rapid
diagnosi
catheterrel
infect
rigor
identifi
mechan
ivdrel
bsi
prospect
studi
necessari
cultur
potenti
sourc
microorgan
time
cathet
remov
fig
skin
insert
site
cathet
hub
infus
lumen
well
implant
cathet
segment
result
cultur
appear
link
bsi
microorgan
isol
one
portion
devic
phenotyp
criteria
effort
need
made
conclus
establish
concord
beyond
speciat
antimicrobi
suscept
pattern
use
one
molecular
subtyp
system
multilocu
enzym
electrophoresi
plasmid
profi
le
restrictionenzym
digest
genom
dna
analyz
pulsedfi
eld
electrophoresi
method
describ
earlier
requir
remov
devic
confi
rmation
ivdrel
bsi
pose
formid
challeng
manag
longterm
surgic
implant
ivd
hickman
broviac
cathet
cuf
tunnel
hemodialysi
cathet
subcutan
central
venou
port
longterm
ivd
remov
suspect
infect
truli
colon
infect
time
remov
avoid
unnecessari
remov
ivd
method
develop
diagnos
ivdrel
bsi
allow
devic
remain
place
pair
quantit
blood
cultur
drawn
ivd
percutan
peripher
vein
differenti
time
posit
dtp
pair
standard
blood
cultur
one
drawn
ivd
peripher
vein
laboratori
avail
autom
quantit
system
cultur
blood
eg
isol
lysiscentrifug
system
wampol
laboratori
cranburi
nj
quantit
blood
cultur
drawn
ivd
concomitantli
venipunctur
peripher
vein
anoth
ivd
permit
diagnosi
ivdrel
bacteremia
fungemia
made
sensit
specifi
citi
rang
without
remov
cathet
empir
antimicrobi
therapi
yet
initi
ivddrawn
cultur
demonstr
higher
concentr
microorgan
per
millilit
compar
count
microorgan
obtain
cultur
drawn
peripher
vein
confi
rm
presenc
ivdrel
bsi
differentialtimetoposit
dtp
pair
blood
cultur
one
drawn
ivd
second
concomitantli
peripher
vein
also
shown
reliabl
identifi
ivdrel
bsi
longterm
ivd
blood
cultur
drawn
ivd
turn
posit
hour
cultur
drawn
peripher
studi
patient
longterm
ivd
sensit
specifi
citi
dtp
rang
respect
perform
dtp
shortterm
ivd
recent
examin
disappoint
result
fi
nding
entir
unexpect
given
predomin
extralumin
rout
infect
devic
diagnos
infect
caus
contamin
infus
sampl
iv
fl
uid
aspir
line
cultur
quantit
qualit
concord
posit
peripher
blood
cultur
without
anoth
identifi
abl
sourc
patient
bsi
defi
nitiv
implic
infect
infus
caus
bsi
anaerob
cultur
techniqu
necessari
unless
blood
anoth
biolog
product
involv
prospect
studi
everi
attempt
made
conclus
identifi
presenc
ivdrel
bsi
show
everi
type
ivd
carri
risk
caus
bsi
howev
magnitud
risk
vari
greatli
depend
type
devic
tabl
devic
pose
greatest
risk
ivdrel
bsi
today
cvc
mani
form
see
tabl
shortterm
noncuf
singlelumen
multilumen
cathet
insert
percutan
subclavian
intern
jugular
vein
shown
rate
catheterrel
bsi
rang
per
ivdday
far
lower
rate
infect
encount
surgic
implant
cuf
hickman
broviac
cathet
subcutan
central
venou
port
per
ivdday
respect
contrari
popular
belief
peripher
insert
central
cathet
picc
use
inpati
arteri
cathet
associ
rate
catheterrel
bsi
approach
seen
shortterm
noncuf
nontunnel
multilumen
cvcsup
bsi
per
ivdday
respect
two
major
sourc
ivdrel
bsi
exist
colon
ivd
catheterrel
infect
contamin
fl
uid
administ
devic
infusaterel
infect
contamin
infus
caus
epidem
ivdrel
bsi
contrast
catheterrel
infect
respons
endem
ivdrel
bsi
order
microorgan
caus
catheterrel
infect
must
fi
rst
gain
access
extralumin
intralumin
surfac
devic
adher
becom
incorpor
biofi
lm
allow
sustain
infect
hematogen
dissemin
microorgan
gain
access
bloodstream
one
three
mechan
see
fig
skin
organ
invad
percutan
tract
probabl
assist
capillari
action
time
insert
day
follow
microorgan
contamin
cathet
hub
lumen
cathet
insert
percutan
guidewir
later
manipul
organ
carri
hematogen
implant
ivd
remot
sourc
local
infect
pneumonia
shortterm
ivd
eg
place
day
peripher
iv
cathet
arteri
cathet
noncuf
nontunnel
cvc
devicerel
bsi
cutan
origin
insert
site
gain
access
extralumin
occasion
intralumin
insert
guidewir
contrast
contamin
cathet
hub
lumin
fl
uid
predomin
mode
invas
infect
longterm
ivd
eg
place
day
cuf
hickmanand
broviactyp
cathet
subcutan
central
port
picc
also
import
recogn
infus
parenter
fl
uid
blood
product
iv
medic
administ
ivd
also
occasion
becom
contamin
produc
devicerel
bsi
contamin
fl
uid
fortun
infrequ
caus
endem
infusionrel
infect
shortterm
ivd
howev
import
caus
bsi
arteri
cathet
use
hemodynam
monitor
longterm
ivd
hickman
broviac
cathet
cuf
hemodialysi
cvc
subcutan
central
venou
port
nosocomi
epidem
infusionrel
bsi
trace
contamin
infus
gramneg
bacilli
introduc
manufactur
intrins
contamin
prepar
administr
hospit
extrins
contamin
epidem
suspect
epidemiolog
approach
must
method
thorough
yet
expediti
direct
toward
establish
bona
fi
de
natur
put
epidem
infect
ie
rule
pseudoinfect
confi
rming
exist
epidem
defi
ning
reservoir
mode
transmiss
epidem
pathogen
importantli
control
epidem
quickli
complet
control
measur
predic
accur
delin
epidemiolog
epidem
pathogen
essenti
step
deal
suspect
nosocomi
outbreak
recent
review
discuss
later
recent
year
factor
associ
increas
risk
ivdrel
bsi
becom
better
delin
tabl
prolong
hospit
sever
ill
clearli
infl
uenc
risk
clinic
state
granulocytopenia
aid
bone
marrow
transplanta
tion
associ
fourfold
sixfold
increas
rate
ivdrel
bsi
howev
featur
ivd
insert
mainten
appear
far
greater
impact
overal
risk
infect
patient
merrer
colleagu
found
insert
ivd
femor
versu
subclavian
vein
associ
greatli
increas
risk
infect
versu
bsi
per
ivdday
p
thrombot
complic
versu
p
moreov
robert
colleagu
found
patient
primari
bsi
like
receiv
care
time
lower
nursingtopati
ratio
higher
proport
temporari
fl
oat
nurs
rather
fulltim
nurs
staff
microbiolog
figur
summar
microbi
profi
le
ivdrel
bsi
publish
prospect
studi
might
expect
knowledg
pathogenesi
infect
skin
microorgan
account
largest
proport
infect
recommend
prevent
ivdrel
bsi
publish
hospit
infect
control
practic
advisori
committe
hicpac
sever
year
ago
tabl
summar
recommend
hicpac
guidelin
prevent
ivdrel
bsi
score
recommend
basi
qualiti
avail
scientifi
c
evid
must
reaffi
rmed
measur
prevent
nosocomi
infect
must
wherev
possibl
base
best
understand
pathophysiolog
epidemiolog
whenev
possibl
control
clinic
trial
choic
cathet
site
devic
insert
obvious
choic
ivd
insert
patient
guid
primarili
patient
particular
need
eg
hemodialysi
versu
fl
uid
administr
howev
astut
clinician
mitig
much
risk
associ
vascular
access
choos
best
devic
task
hand
insert
ivd
locat
associ
least
risk
infect
studi
suggest
multilumen
ivd
associ
higher
risk
infect
singlelumen
cathet
said
patient
need
multipl
infus
insert
sever
singl
lumen
cathet
pose
greater
risk
singl
multilumen
cathet
date
random
studi
design
evalu
optim
locat
placement
shortterm
cvc
howev
data
accumul
numer
observ
studi
suggest
lowest
risk
ivdrel
bsi
seen
subclavian
vein
insert
highest
risk
femor
vein
insert
intermedi
level
risk
associ
jugular
vein
insert
femor
vein
often
use
central
venou
access
especi
nonsurg
servic
eas
cannul
lower
risk
mechan
complic
insert
ie
bleed
pneumothorax
unfortun
prospect
studi
evalu
risk
femor
vein
devic
placement
shown
cvc
place
femor
vein
like
colon
time
remov
cathet
place
intern
jugular
vein
rr
ci
p
associ
increas
risk
ivdrel
bsi
compar
cvc
place
subclavian
vein
versu
p
furthermor
recent
prospect
studi
found
higher
rate
catheterrel
deep
vein
thrombosi
femor
cathet
rang
gener
believ
femor
access
use
emerg
access
requir
inexperi
oper
limit
placement
upper
bodi
contraind
placement
upper
bodi
avail
site
extens
burn
sever
coagulopathi
shortterm
cvc
must
place
femor
vein
arteri
believ
import
cathet
insert
site
locat
least
inch
cm
inguin
creas
intertrigin
area
heavili
colon
bowel
organ
yeast
also
allow
secur
protect
dress
affi
xed
contrast
shortterm
cvc
observ
studi
hemodialysi
cathet
abl
confi
rm
lower
rate
infect
cathet
insert
subclavian
vein
compar
insert
intern
jugular
vein
although
still
excess
risk
associ
femor
vein
placement
technolog
use
antimicrobialco
antisepticimpregn
cvc
adult
patient
institut
rate
ib
bsi
high
despit
consist
applic
prevent
measur
cathet
like
remain
place
day
data
recommend
pediatr
patient
use
chlorhexidineimpregn
spong
dress
adolesc
adult
patient
uncuf
nr
cvc
cathet
like
remain
place
day
recommend
children
use
neonat
younger
day
old
gestat
age
younger
wk
use
prophylact
antibiot
lock
solut
patient
longterm
ivd
ii
continu
experi
ivdrel
bsi
despit
consist
applic
infect
control
practic
taken
cdchicpac
system
weight
recommend
base
scientifi
c
evid
ia
strongli
recommend
implement
support
welldesign
experiment
clinic
epidemiolog
studi
ib
strongli
recommend
implement
support
experiment
clinic
epidemiolog
studi
strong
theoret
rational
ic
requir
state
feder
regul
rule
standard
ii
suggest
implement
support
suggest
clinic
epidemiolog
trial
theoret
rational
unresolv
issu
unresolv
issu
evid
insuffi
cient
consensu
regard
effi
caci
exist
nr
recommend
time
subclavian
vein
approach
compar
rate
cathet
insert
intern
jugular
vein
basi
data
intern
jugular
vein
insert
prefer
subclavian
vein
insert
central
access
hemodialysi
hand
hygien
antisepticcontain
prepar
either
convent
handwash
chlorhexidin
waterless
alcohol
rub
gel
must
alway
preced
insert
ivd
also
preced
subsequ
handl
devic
administr
set
new
pair
dispos
nonsteril
glove
use
notouch
techniqu
adequ
placement
peripher
iv
cathet
patient
howev
steril
glove
use
insert
highrisk
patient
granulocytopenia
steril
glove
strongli
recommend
placement
type
ivd
associ
higher
risk
associ
bacteremia
specifi
calli
arteri
cathet
type
central
place
devic
includ
picc
studi
shown
use
maxim
barrier
includ
longsleev
steril
surgic
gown
mask
cap
larg
steril
drape
steril
glove
significantli
reduc
risk
cvcrelat
bsi
bsi
maxim
barrier
versu
bsi
per
ivdday
without
maxim
barrier
p
use
maxim
barrier
shown
highli
cost
effect
consid
ivd
cvc
like
produc
nosocomi
bsi
strong
case
made
mandat
maxim
barrier
precaut
insert
central
ivd
necessari
howev
arteri
cathet
use
hemodynam
monitor
steril
glove
steril
fenestr
drape
suffi
ce
iv
team
good
techniqu
also
essenti
studi
shown
use
special
iv
therapi
team
consist
train
nurs
technician
assur
consist
high
level
asept
techniqu
cathet
insert
followup
care
cathet
associ
substanti
lower
rate
catheterrel
bsi
cost
effect
even
institut
iv
team
greatli
reduc
rate
ivdrel
bsi
formal
educ
nurs
physician
stringent
adher
ivd
care
protocol
cutan
antisepsi
given
evid
import
cutan
microorgan
pathogenesi
shortterm
ivdrel
infect
measur
reduc
colon
insert
site
would
seem
highest
prioriti
particularli
choic
chemic
antisept
disinfect
site
nine
random
prospect
trial
compar
chlorhexidinecontain
antisept
either
povidoneiodin
alcohol
prepar
skin
prior
insert
shortterm
ivd
report
largest
studi
date
random
trial
cvc
arteri
cathet
place
univers
hospit
icu
cutan
antisepsi
tinctur
chlorhexidin
show
highli
signifi
cant
reduct
ivdrel
bsi
compar
iodophor
rr
p
recent
metaanalysi
examin
result
eight
nine
aforement
studi
found
use
chlorhexidin
associ
nearli
reduct
risk
ivdrel
compar
povidoneiodin
rr
ci
insert
site
care
ivd
mainten
ivd
dress
ivd
dress
steril
gauz
tape
steril
transpar
semiperm
polyurethan
fi
lm
dress
avail
data
suggest
two
type
dress
equival
term
impact
ivdrel
bsi
peripher
iv
shortterm
cvc
contrast
result
studi
arteri
cathet
found
polyurethan
dress
greatli
increas
risk
ivdrel
bsi
result
polyurethan
dress
probabl
use
arteri
cathet
futur
studi
confi
rm
safeti
topic
antimicrobi
ointment
theori
applic
topic
antimicrobi
agent
cathet
insert
site
confer
protect
microbi
invas
clinic
trial
topic
combin
antibacteri
ointment
contain
polymyxin
neomycin
bacitracin
peripher
iv
shown
margin
benefi
use
polyantibiot
ointment
associ
fi
vefold
increas
frequenc
candida
infect
limit
util
topic
antibacteri
mupirocin
activ
primarili
gramposit
organ
shown
one
studi
signifi
cantli
reduc
colon
intern
jugular
cathet
without
increas
colon
candida
spp
recent
studi
sesso
colleagu
show
signifi
cant
reduct
hemodialysi
cathet
colon
versu
per
ivdday
p
aureu
ivdrel
bsi
versu
bsi
per
ivdday
p
unfortun
resist
aureu
coagulaseneg
staphylococci
rapidli
emerg
widescal
mupirocin
use
contraven
use
topic
agent
prevent
ivdrel
bsi
time
three
prospect
studi
topic
povidoneiodin
ointment
appli
central
venou
cathet
site
fail
show
statist
benefi
use
singl
compar
trial
subclavian
hemodialysi
cathet
show
use
topic
povidoneiodin
ointment
associ
fourfold
reduct
incid
ivdrel
aureu
bsi
therefor
topic
agent
use
hemodialysi
cathet
iodophor
may
desir
replac
devic
studi
shown
peripher
iv
may
safe
left
place
hour
patient
insert
site
monitor
close
studi
suggest
durat
peripher
catheter
may
prolong
even
view
report
increas
nosocomi
aureu
bacteremia
link
prolong
peripher
venou
catheter
studi
requir
becom
consid
accept
routin
schedul
replac
shortterm
noncuf
nontunnel
cvc
long
practic
mani
center
howev
studi
call
practic
question
moreov
metaanalysi
found
benefi
routin
replac
shortterm
cvc
basi
data
appear
indic
schedul
replac
shortterm
cvc
function
well
show
clinic
sign
infect
cvc
must
replac
either
mechan
malfunct
suspect
infect
deserv
special
attent
replac
cvc
guidewir
exchang
associ
reduc
risk
mechan
complic
howev
also
associ
increas
risk
newli
place
cvc
becom
infect
caus
cvcrelat
bsi
result
circumst
necessit
guidewir
exchang
placement
new
cathet
eg
patient
limit
site
access
morbidli
obes
high
risk
mechan
complic
underli
coagulopathi
strict
asept
techniqu
includ
full
barrier
precaut
must
use
howev
tip
andor
intracutan
segment
remov
cvc
routin
sent
cultur
determin
whether
insert
tract
colon
newli
insert
cvc
promptli
remov
new
cvc
place
percutan
new
site
tract
colon
newli
exchang
cvc
remain
old
insert
site
although
small
studi
found
util
guidewir
exchang
manag
cvc
suspect
infect
believ
absenc
random
studi
demonstr
safeti
guidewir
exchang
gener
perform
suspicion
ivdrel
bsi
especi
sign
local
infect
purul
erythema
insert
site
sign
system
sepsi
without
sourc
case
old
cathet
remov
cultur
new
cathet
insert
new
site
replac
deliveri
system
wherea
infusionrel
bsi
caus
infect
devic
use
vascular
access
infus
occasion
becom
contamin
caus
endem
bsi
infus
run
continu
extend
period
cumul
risk
contamin
increas
risk
contamin
grow
concentr
could
produc
bsi
recipi
fl
uid
year
us
hospit
routin
replac
entir
deliveri
system
patient
iv
infus
interv
reduc
risk
bsi
extrins
contamin
fl
uid
prospect
studi
indic
iv
deliveri
system
need
replac
frequent
everi
hour
includ
infus
use
total
parenter
nutrit
infus
icu
patient
extend
durat
use
permit
cost
save
hospit
four
clinic
set
might
regard
except
use
hour
interv
routin
set
chang
administr
blood
product
administr
lipid
emuls
arteri
pressur
monitor
suspicion
epidem
infusionrel
bsi
circumst
may
prudent
administr
set
chang
routin
interv
arteri
infus
use
hemodynam
monitor
appear
vulner
becom
contamin
use
produc
endem
epidem
septicemia
caus
gramneg
bacilli
infus
hemodynam
monitor
set
fl
uid
fl
ow
continu
system
thu
elimin
blind
stagnant
column
fl
uid
extrins
contamin
appear
greatli
reduc
may
even
elimin
need
replac
administr
set
transduc
assembl
compon
system
frequent
interv
dispos
transduc
use
appear
need
replac
transduc
assembl
compon
deliveri
system
frequent
everi
day
may
safe
replac
even
less
frequent
anticoagul
thrombu
format
intravascular
devic
associ
increas
risk
infect
two
prospect
studi
perform
examin
effi
caci
warfarin
anticoagul
reduc
rate
ivdassoci
thrombosi
longterm
ivd
studi
found
use
warfarin
dose
mgday
associ
signifi
cantli
reduc
rate
thrombosi
longterm
ivd
although
data
provid
rate
ivdrel
bsi
use
prophylact
heparin
reduc
rate
ivdrel
thrombosi
infect
evalu
metaanalysi
examin
varieti
differ
administr
techniqu
random
control
studi
randolph
colleagu
conclud
system
heparin
signifi
cantli
reduc
risk
ivdassoci
thrombosi
rr
ci
devic
colon
rr
ci
fail
show
reduct
ivdrel
bsi
heparinbond
pulmonari
arteri
cathet
may
less
prone
ivdrel
bsi
nonheparin
cathet
basi
studi
lowlevel
anticoagul
warfarin
warrant
longterm
ivd
long
contraind
bleed
diathesi
brain
tumor
predilect
fall
inr
maintain
shortterm
ivd
use
lowdos
subcutan
heparin
appropri
commonli
given
patient
cvc
arteri
line
part
icu
thromboembol
prophylaxi
despit
complianc
recommend
guidelin
mani
center
continu
high
rate
ivdrel
bsi
novel
technolog
hold
much
promis
tabl
innov
technolog
design
reduc
risk
ivdrel
bsi
prove
effect
also
reduc
health
care
cost
shortterm
longterm
ivd
random
trial
devic
prematur
loss
pediatr
picc
caus
accident
extrus
piccassoci
thrombosi
signifi
cantli
reduc
two
addit
trial
incid
catheterrel
bsi
signifi
cantli
reduc
use
novel
secur
devic
adult
children
picc
promis
devic
reduc
infect
may
deriv
elimin
fester
skin
sutur
wound
contigu
newli
insert
cathet
minim
toandfro
movement
cathet
may
promot
invas
tract
cutan
microorgan
capillari
action
novel
dress
studi
polyurethan
dress
contain
antisept
povidoneiodin
ioniz
silver
disappoint
howev
basi
demonstr
superior
chlorhexidin
cutan
disinfect
access
site
novel
chlorhexidineimpregn
spong
dress
develop
biopatch
johnson
johnson
medic
inc
maintain
high
concentr
antisept
insert
site
dress
largest
studi
date
found
use
chlorhexidineimpregn
spong
dress
associ
reduct
catheterrel
bsi
rr
p
although
advers
side
effect
associ
use
dress
trial
adult
pediatr
trial
found
lowbirthweight
neonat
develop
local
dermatotox
antiinfect
impregn
cathet
intravascular
devic
directli
coat
impregn
antimicrobi
antisept
intens
studi
past
decad
eighteen
random
trial
evalu
effi
caci
chlorhexidinesilversulfadiazineor
minocyclinerifampinimpregn
cvc
publish
full
articl
abstract
form
sinc
publish
studi
examin
effect
antimicrobialimpregn
cvc
rate
cvcrelat
bsi
found
either
statist
signifi
cant
reduct
strong
trend
toward
reduct
rate
cvcrelat
bsi
aggreg
analysi
studi
compar
antimicrobialimpregn
cvc
nonimpregn
cvc
encompass
total
cvc
show
antimicrobialimpregn
cvc
associ
reduct
cvcrelat
bsi
devic
versu
devic
ci
p
result
remark
similar
fi
nding
three
publish
metaanalys
final
two
rigor
sophist
econom
analys
found
antimicrobialimpregn
cvc
cost
effect
veenstra
colleagu
show
antimicrobialimpregn
cvc
remain
cost
effect
even
cost
cvcrelat
bsi
low
per
case
cost
save
per
antimicrobialimpregn
cvc
realist
cost
cvcrelat
bsi
use
analysi
shorr
colleagu
show
use
antimicrobialimpregn
cvc
associ
cost
save
per
cvcrelat
bsi
prevent
would
save
everi
patient
receiv
antimicrobialimpregn
cvc
basi
larg
bodi
data
two
nation
advisori
panel
recommend
use
antimicrobialimpregn
cvc
clinic
set
despit
rigor
applic
prevent
intervent
rate
ivdrel
bsi
remain
unaccept
high
ie
bsi
per
ivdday
antimicrobi
lock
solut
given
import
hub
contamin
intralumin
colon
genesi
ivdrel
bsi
longterm
ivd
benzalkonium
chlorideimpregn
cathet
chlorhexidinesilv
sulfadiazineco
cathet
cefazolinco
cathet
minocyclinerifampinco
cathet
silverimpregn
cathet
iodin
chamber
extern
povidoneiodinesatur
spong
cap
intralumin
instil
antibiot
antisept
solut
potenti
reduc
risk
bsi
associ
devic
six
random
prospect
trial
examin
vancomycincontain
antibiot
lock
solut
prevent
ivdrel
bsi
largest
found
use
vancomycin
vancomycinciprofl
oxacin
lock
solut
reduc
risk
ivdrel
bsi
nearli
p
evid
use
lock
solut
promot
colon
infect
vancomycinresist
bacteria
fungi
yet
concern
emerg
resist
prophylact
antibioticcontain
lock
solut
limit
wider
accept
date
howev
use
prophylact
antibiot
lock
solut
consid
accept
hicpac
guidelin
patient
essenti
longterm
ivd
continu
experi
recurr
ivdrel
bsi
despit
consist
applic
infect
control
practic
variou
prophylact
lock
solut
studi
mean
prevent
ivdrel
bsi
includ
trisodium
citrategentamicin
minocyclin
ethylenediaminetetraacet
acid
edta
ethanol
taurolidinecontain
solut
concern
increas
ivd
complic
rate
drugrel
toxic
associ
use
certain
type
lock
solut
combin
limit
number
patient
studi
receiv
agent
preclud
routin
use
time
cathet
hub
novel
cathet
hub
contain
chamber
fi
lled
iodin
alcohol
shown
effect
prevent
colon
ivd
anim
model
use
hub
model
clinic
studi
demonstr
signifi
cantli
lower
rate
ivd
colon
compar
ivd
control
hub
one
clinic
trial
also
demonstr
reduc
rate
ivdrel
bsi
use
hub
versu
p
subsequ
studi
also
show
reduct
hubrel
ivdrel
bsi
versu
p
overal
rate
ivdrel
bsi
group
similar
anoth
studi
unabl
fi
nd
benefi
regard
ivd
colon
ivdrel
bsi
use
novel
hub
devic
yet
avail
unit
state
studi
conclus
demonstr
benefi
use
recommend
time
hospitalacquir
pneumonia
hap
defi
ned
pneumonia
develop
hour
hospit
vap
subset
hap
defi
ned
pneumonia
occur
hour
initi
mechan
ventil
nearli
episod
hap
occur
us
hospit
year
hap
occur
patient
undergo
mechan
ventil
mechan
ventil
patient
develop
vap
vap
second
common
nosocomi
infect
us
icu
particip
nation
nosocomi
infect
surveil
nni
program
median
rate
vap
rang
case
per
ventilatorday
pediatr
unit
case
per
ventilatorday
trauma
unit
tabl
vap
increas
length
hospit
day
health
care
cost
compar
match
control
develop
vap
importantli
vap
associ
nosocomi
death
infect
site
least
death
us
center
annuallyand
increas
hospit
mortal
least
twofold
affect
individu
normal
nonsmok
host
multipl
host
defens
mechan
contribut
protect
pneumonia
respiratori
tract
vocal
cord
normal
heavili
colon
bacteria
unless
person
chronic
bronchiti
respiratori
tract
instrument
lower
respiratori
tract
normal
steril
although
healthi
adult
aspir
frequent
sleep
lower
airway
pulmonari
parenchyma
healthi
nonsmok
person
without
lung
diseas
remark
free
microbi
colon
major
defens
mechan
includ
anatom
airway
barrier
cough
refl
ex
mucu
mucociliari
clearanc
termin
bronchiol
cellular
humor
immun
system
essenti
compon
host
defens
alveolar
macrophag
leukocyt
remov
particul
matter
potenti
pathogen
elabor
cytokin
activ
system
cellular
immun
respons
act
antigenpres
cell
humor
arm
immun
immunoglobulin
complement
opson
bacteria
bacteri
product
within
respiratori
tract
assist
phagocytosi
mechan
ventil
patient
numer
factor
conspir
compromis
host
defens
critic
ill
comorbid
malnutrit
impair
immun
system
endotrach
intub
thwart
cough
refl
ex
compromis
mucociliari
clearanc
injur
tracheal
epitheli
surfac
provid
direct
conduit
bacteria
mouth
hypopharynx
stomach
gain
direct
access
lower
respiratori
tract
moreov
cuff
endotrach
tube
allow
pool
oropharyng
secret
subglott
region
form
ideal
medium
microbi
growth
period
leak
around
cuff
trachea
would
probabl
accur
pathogen
renam
vap
endotrach
intubationrel
pneumonia
combin
impair
host
defens
continu
exposur
lower
respiratori
tract
larg
number
potenti
pathogen
endotrach
tube
put
mechan
ventil
patient
great
jeopardi
develop
vap
order
microorgan
caus
vap
must
fi
rst
gain
access
normal
steril
lower
respiratori
tract
adher
mucosa
produc
sustain
infect
microorgan
gain
access
one
four
mechan
fig
aspir
microbeladen
secret
either
oropharynx
directli
secondarili
refl
ux
stomach
oropharynx
lower
respiratori
tract
inhal
contamin
air
medic
aerosol
direct
extens
contigu
infect
pleural
space
infect
hematogen
carriag
microorgan
lung
remot
site
local
infect
ivdrel
bsi
although
numer
epidem
vap
caus
contamin
aerosol
medic
respiratori
devic
preponder
evid
suggest
endem
vap
deriv
aspir
oropharyng
organ
oropharynx
critic
ill
patient
rapidli
colon
pathogen
caus
vap
especi
aerob
gramneg
aureu
studi
multipl
anatom
site
cultur
simultan
time
shown
pathogen
microorgan
implic
vap
usual
fi
rst
recov
oropharynx
later
tracheobronchi
tree
stomach
moreov
heavi
oropharyng
colon
power
independ
predictor
subsequ
tracheobronchi
colon
vap
reduc
oropharyng
colon
topic
antimicrobi
antisept
shown
signifi
cantli
reduc
risk
vap
rout
aspir
oropharyng
content
contain
larg
microbi
inoculum
overwhelm
host
defens
alreadi
compromis
critic
ill
presenc
endotrach
tube
readili
lead
develop
vap
pathogen
caus
vap
may
part
host
endogen
fl
ora
time
hospit
may
acquir
exogen
admiss
health
care
institut
hand
apparel
equip
hcw
hospit
environ
use
invas
devic
see
fig
normal
fl
ora
oropharynx
nonintub
patient
without
critic
ill
compos
predominantli
viridan
streptococci
haemophilu
speci
anaerob
salivari
fl
ow
protein
immunoglobulin
fi
bronectin
major
host
factor
maintain
normal
fl
ora
mouth
dental
plaqu
aerob
gramneg
bacilli
rare
recov
oral
secret
healthi
patient
critic
ill
especi
icu
patient
oral
fl
ora
shift
dramat
predomin
aerob
gramneg
bacilli
aureu
bacteri
adher
orotrach
mucosa
mechan
ventil
patient
assist
reduc
mucos
iga
increas
proteas
product
expos
denud
mucou
membran
elev
airway
ph
increas
number
airway
receptor
bacteria
acut
ill
antimicrobi
use
earlyonset
vap
manifest
within
fi
rst
day
hospit
often
caus
communityacquir
pathogen
pneumonia
haemophilu
speci
fig
howev
microbi
spectrum
vap
shift
typic
nosocomi
pathogen
increas
length
mechan
ventil
exposur
broadspectrum
antimicrobi
see
fig
preponder
episod
vap
late
onset
support
fact
common
pathogen
recov
mechan
ventil
patient
pneumonia
p
aeruginosa
aureu
enterobacteriacea
fig
vap
polymicrobi
case
role
anaerob
bacteria
vap
well
defi
ned
hospit
particip
cdc
nation
nosocomi
infect
surveil
system
nni
use
standard
defi
nition
hap
unfortun
even
use
combin
specifi
citi
clinic
criteria
poor
overal
diagnost
accuraci
approxim
publish
studi
reason
expert
advoc
routin
use
invas
procedur
vap
suspectedbronchoalveolar
lavag
bal
cultur
protect
specimen
brush
psb
sampl
obtain
bronchoscopi
blind
mini
bal
ground
diagnost
techniqu
compar
sensit
greater
specifi
citi
superior
accuraci
clinic
criteria
alon
whether
rigor
clinic
criteria
clinic
pneumonia
infect
score
cpi
exampl
use
quantit
cultur
endotrach
aspir
improv
diagnost
accuraci
without
need
invas
procedur
unsettl
issu
although
invas
proceduresb
psb
minibalar
clearli
specifi
c
clinic
criteria
impact
patient
outcom
much
less
clear
fagon
colleagu
found
patient
suspect
vap
manag
use
invas
diagnost
approachbronchoscopicguid
psb
balhad
signifi
cantli
reduc
mortal
reduc
antibioticday
reduc
mortal
multivari
analysi
compar
patient
manag
use
clinic
diagnost
approach
hr
ci
p
recent
howev
heyland
colleagu
found
larg
multicent
canadian
trial
mortal
target
antimicrobi
use
ident
among
patient
random
invas
versu
clinic
diagnost
approach
studi
critic
exclus
subject
high
risk
infect
antimicrobialresist
pathogen
absenc
defi
nitiv
data
demonstr
superior
either
approach
recent
american
thorac
societysocieti
critic
care
medicineinfecti
diseas
societi
america
joint
guidelin
acknowledg
diagnost
approach
use
accept
evalu
patient
suspect
vap
put
great
weight
initi
gram
stain
deep
tracheal
aspir
howev
microorgan
seen
conclud
unlik
patient
bacteri
vap
number
independ
risk
factor
shown
increas
likelihood
develop
vap
tabl
gener
risk
factor
categor
factor
increas
likelihood
durat
mechan
ventil
factor
increas
colon
oropharynx
gastric
mucosa
factor
increas
likelihood
aspir
host
factor
increas
suscept
infect
prolong
mechan
ventil
reintub
power
predictor
develop
vap
cunnion
colleagu
found
mechan
ventil
excess
hour
associ
increas
risk
develop
vap
trouillet
found
ventil
longer
day
associ
sixfold
increas
risk
emerg
reintub
also
carri
high
risk
aspir
associ
sixfold
increas
risk
vap
retrospect
studi
poor
dental
hygien
increas
bacteri
burden
oropharynx
independ
risk
factor
nosocomi
pneumonia
likewis
high
gastric
ph
associ
greatli
increas
bacteri
colon
gastric
content
well
increas
risk
vap
number
studi
found
exposur
antacid
h
blocker
associ
increas
risk
vap
although
univers
fi
nding
depress
level
conscious
nasogastr
tube
endotrach
tube
ubiquit
icu
increas
patient
risk
aspir
alter
level
cognit
associ
increas
risk
aspir
support
surveil
data
show
increas
rate
vap
trauma
neurosurg
icu
colleagu
found
use
nasogastr
tube
independ
predictor
vap
multivari
analysi
ci
final
note
endotrach
tube
allow
pool
hypopharyng
secret
leak
around
cuff
directli
trachea
supin
posit
appear
increas
risk
aspir
around
cuff
host
factor
also
contribut
increas
risk
develop
vap
see
tabl
condit
advanc
age
increas
sever
ill
postsurg
state
rare
modifi
abl
howev
poor
nutrit
statu
oversed
transfus
therapi
exposur
broadspectrum
antimicrobi
associ
increas
risk
vap
control
clinician
understand
pathogenesi
epidemiolog
hand
clinician
care
mechan
ventil
patient
implement
prevent
strategi
materi
reduc
risk
vap
tabl
cdc
hicpac
canadian
critic
care
trial
group
offer
evidencebas
guidelin
prevent
vap
recommend
similar
minor
differ
canadian
guidelin
focus
exclus
specifi
c
intervent
prevent
vap
wherea
hicpac
guidelin
incorpor
addit
guidanc
prevent
nosocomi
infl
uenza
legionellosi
invas
fi
lament
fungal
infect
hospit
recommend
guidelin
divid
gener
nonpharmacolog
pharmacolog
prevent
measur
see
tabl
gener
measur
employ
reduc
vap
includ
educ
infect
control
hand
hygien
reliabl
disinfect
steril
respiratori
care
equip
discuss
elsewher
chapter
avoid
prolong
intub
reintubationif
avoid
intub
altogeth
feasibleoff
greatest
promis
reduc
individu
patient
risk
develop
vap
use
noninvas
ventil
order
avoid
endotrach
intub
shown
success
reduc
rate
nosocomi
pneumonia
number
studi
may
abrog
need
reintub
select
patient
prematur
extub
implement
wean
protocol
also
shown
signifi
cantli
reduc
durat
mechan
ventil
health
care
cost
institut
rate
vap
earli
tracheostomywithin
week
intubationha
advoc
method
reduc
risk
vap
patient
like
requir
prolong
mechan
ventil
howev
random
trial
admittedli
limit
power
found
signifi
cant
benefi
approach
earli
tracheostomi
current
recommend
author
note
earlier
supin
posit
mechan
ventil
patient
head
shown
increas
risk
gastroesophagealpharyng
aspir
simpl
solut
threat
elev
head
patient
bed
degre
drakulov
colleagu
found
patient
whose
torso
head
kept
elev
degre
much
lower
rate
microbiolog
confi
rmed
pneumonia
compar
patient
care
supin
posit
versu
p
realiti
maintain
elev
head
excess
degre
consist
basi
actual
quit
diffi
cult
uncommonli
achiev
practic
recent
random
studi
sought
maintain
head
elev
degre
studi
period
found
head
elev
intervent
arm
averag
degre
perhap
result
failur
success
achiev
adequ
elev
reduct
rate
vap
seen
although
data
effect
comprehens
oral
care
risk
infect
limit
maintain
adequ
dental
hygien
consid
import
compon
vap
prevent
binkley
colleagu
found
although
major
nurs
care
patient
undergo
mechan
ventil
appreci
import
dental
hygien
method
use
provid
vari
consider
data
avail
specifi
c
dental
hygien
practic
recommend
mechan
ventil
patient
teeth
brush
daili
undergo
oral
cleans
everi
hour
undergo
routin
suction
reduc
accumul
fl
uid
oropharynx
mouth
moistur
appli
lip
prevent
crack
period
instil
topic
oral
antisept
solut
addit
promis
intervent
discuss
pharmacolog
prevent
measur
later
use
modifi
ed
endotrach
tube
separ
ventral
drainag
tube
continu
intermitt
suction
subglott
secret
evalu
number
studi
subglott
suction
reduc
rate
vap
signifi
cantli
one
studi
howev
latter
studi
time
onset
vap
delay
signifi
cantli
day
versu
day
p
recent
evidencebas
guidelin
recommend
use
endotrach
tube
allow
suction
subglott
secret
nevertheless
use
endotrach
tube
allow
subglott
suction
reduc
durat
mechan
ventil
icu
mortal
studi
done
coupl
increas
cost
tube
propens
suction
lumen
occlud
limit
wider
adopt
technolog
practic
evid
heat
moistur
exchang
hme
associ
reduc
risk
vap
mix
one
six
publish
trial
found
statist
signifi
cant
reduct
vap
use
hme
rr
ci
p
howev
pool
data
recent
systemat
review
subsequ
publish
random
trial
show
hme
reduc
risk
vap
rr
ci
p
use
hme
recommend
author
systemat
review
current
recommend
canadian
critic
care
trial
group
howev
hicpac
made
recommend
use
hme
fi
six
publish
trial
fail
demonstr
statist
signifi
cant
reduct
rate
vap
heat
exchang
moistur
becom
readili
occlud
patient
airway
hemorrhag
increas
airway
resist
result
use
patient
hemoptysi
requir
highminut
ventil
final
membran
hme
becom
colon
bacteria
replac
weekli
accord
current
guidelin
avail
inlin
multius
suction
cathet
abrog
need
open
manipul
endotrach
circuit
theoret
reduc
risk
exogen
contamin
despit
theoret
benefi
prospect
studi
consist
show
inlin
suction
cathet
associ
reduc
risk
vap
although
inlin
suction
cathet
appear
increas
risk
vap
time
effi
cient
nurs
personnel
respiratori
therapist
cost
effect
open
suction
cathet
kollef
colleagu
found
rate
vap
ident
patient
random
asneed
chang
inlin
suction
cathet
versu
cathet
chang
everi
hour
versu
result
compel
evid
inlin
suction
cathet
period
chang
unless
clinic
indic
antacid
h
blocker
use
extens
icu
set
prevent
stress
ulcer
bleed
associ
increas
risk
develop
vap
lead
bacteri
overgrowth
gastric
content
sucralf
prevent
stress
ulcer
bleed
without
reduc
gastric
ph
diffi
cult
administ
less
effect
acidreduc
agent
result
clinic
trial
examin
two
compet
strategi
prevent
gastrointestin
hemorrhag
icu
mix
earlier
trial
favor
use
sucralf
howev
recent
publish
trial
suggest
small
increment
increas
risk
vap
h
blocker
expert
feel
risk
offset
superior
capac
prevent
stress
ulcer
bleed
select
digest
decontamin
sdd
one
extens
studi
prevent
intervent
critic
care
medicin
yet
role
sdd
continu
gener
vigor
debat
overal
benefi
detail
discuss
risk
benefi
ts
intervent
provid
later
chapter
us
expert
believ
sdd
potenti
increas
infect
caus
multiresist
bacteria
particularli
set
high
rate
endem
antimicrobi
resist
welldesign
multicent
trial
done
prove
sdd
advers
effect
icu
ecolog
like
north
american
guidelin
continu
discourag
use
isol
use
parenter
antimicrobi
prevent
vap
met
much
success
select
antimicrobi
decontamin
oropharynx
without
use
enter
system
agent
reduc
risk
vap
nearli
rr
ci
p
recent
trial
studi
reemphas
primari
role
oropharyng
colon
pathogenesi
vap
engend
concern
sdd
potenti
promot
antimicrobi
resist
howev
facilit
idea
topic
decolon
oropharynx
nonantimicrobi
agent
might
abl
materi
reduc
risk
vap
without
potenti
emerg
antimicrobi
resist
recent
metaanalysi
seven
random
trial
enrol
mechan
ventil
patient
found
topic
chlorhexidin
appli
oropharynx
reduc
risk
vap
nearli
rr
ci
p
although
signifi
cant
impact
mortal
benefi
cial
effect
chlorhexidin
appear
pronounc
postcardiac
surgeri
patient
prompt
hicpac
recommend
use
subpopul
year
urinari
cathet
insert
million
patient
acutecar
hospit
extendedcar
facil
catheterassoci
urinari
tract
infect
cauti
common
nosocomi
infect
hospit
nurs
home
compris
institut
acquir
infect
nosocomi
bacteriuria
candiduria
develop
patient
requir
urinari
cathet
day
daili
risk
cauti
second
common
caus
nosocomi
bloodstream
infect
studi
also
found
increas
mortal
associ
cauti
although
cauti
asymptomat
rare
extend
hospit
add
direct
cost
acutecar
hospit
asymptomat
infect
commonli
precipit
unnecessari
antimicrobialdrug
therapi
cauti
compris
perhap
largest
institut
reservoir
nosocomi
antibioticresist
pathogen
import
multidrugresist
enterobacteriacea
escherichia
coli
klebsiella
enterobact
proteu
citrobact
pseudomona
aeruginosa
enterococci
staphylococci
candida
spp
exclud
rare
hematogen
deriv
pyelonephr
caus
almost
exclus
aureu
microorgan
caus
endem
cauti
deriv
patient
colon
perin
fl
ora
hand
health
care
personnel
gain
access
patient
urinari
tract
cathet
insert
manipul
collect
system
organ
gain
access
one
two
way
extralumin
contamin
may
occur
earli
direct
inocul
cathet
insert
later
organ
ascend
perineum
capillari
action
thin
mucou
fi
lm
extern
cathet
surfac
urethr
wall
intralumin
contamin
occur
refl
ux
microorgan
gain
access
cathet
lumen
failur
close
drainag
contamin
urin
collect
bag
recent
studi
suggest
cauti
frequent
stem
microorgan
gain
access
bladder
extralumin
rout
import
infect
urinari
cathet
cover
thick
biofi
lm
contain
infect
microorgan
embed
matrix
host
protein
microbi
exoglycocalyx
biofi
lm
form
intralumin
extralumin
surfac
implant
cathet
usual
advanc
retrograd
fashion
role
biofi
lm
pathogenesi
cauti
establish
howev
antiinfectiveimpregn
silverhydrogel
cathet
inhibit
adher
microorgan
cathet
surfac
signifi
cantli
reduc
risk
cauti
particularli
infect
caus
gramposit
organ
yeast
like
acquir
extralumin
periurethr
fl
ora
data
suggest
microbi
adher
cathet
surfac
import
pathogenesi
mani
cauti
infect
biofi
lm
play
pathogen
role
probabl
caus
mass
transport
intralumin
contamin
bladder
retrograd
refl
ux
microbeladen
urin
cathet
collect
system
move
manipul
sever
cathetercar
practic
univers
recommend
prevent
least
delay
onset
cauti
importantli
avoid
unnecessari
catheter
consid
use
condom
cathet
male
suprapub
cathet
train
profession
insert
cathet
asept
remov
cathet
soon
longer
need
maintain
uncompromis
close
drainag
ensur
depend
drainag
much
possibl
minim
manipul
system
separ
catheter
patient
geograph
patient
care
unit
note
earlier
technolog
innov
prevent
nosocomi
infect
like
effect
base
clear
understand
pathogenesi
epidemiolog
infect
novel
technolog
must
design
block
cauti
either
extralumin
intralumin
rout
medic
cathet
reduc
adher
microorgan
cathet
surfac
may
confer
greatest
benefi
prevent
cauti
two
cathet
impregn
antiinfect
solut
studi
random
trial
one
impregn
urinari
antisept
nitrofurazon
new
broadspectrum
antimicrobialdrug
combin
minocyclin
rifampin
cathet
show
modest
reduct
bacteri
cauti
howev
studi
small
risk
select
antimicrobi
drugresist
uropathogen
satisfactorili
resolv
silver
compound
also
studi
coat
urinari
cathet
metaanalysi
eight
random
trial
compar
silver
oxid
silver
alloy
cathet
standard
nonimpregn
cathet
found
silver
alloy
silver
oxid
cathet
associ
reduc
risk
cauti
recommend
prevent
cauti
summar
tabl
past
year
differ
class
parenter
antimicrobi
sever
hundr
antimicrobi
compound
introduc
clinic
use
public
health
offi
cial
confi
dentli
declar
war
infecti
diseas
almost
unfortun
clear
side
victori
although
greatest
stride
struggl
infecti
diseas
result
improv
hygien
social
condit
grow
loss
antibiot
armamentarium
result
surg
bacteri
resist
could
ultim
disastr
icu
patient
tide
stem
antimicrobi
resist
evolv
sever
phase
resist
aerob
gramneg
bacilli
major
concern
p
aeruginosa
broad
rang
intrins
acquir
resist
quintessenti
nosocomi
pathogen
avail
antibiot
varieti
distinct
classesaminoglycosid
broadspectrum
penicillin
eg
piperacillin
monobactam
eg
aztreonam
carbapenem
eg
imipenem
inhibitor
eg
piperacillintazobactam
trimethoprimsulfamethoxazol
fl
uoroquinolonespromis
respit
concern
resist
aerob
gramneg
bacilli
period
howev
gramposit
cocci
gain
promin
mrsa
coagulaseneg
staphylococci
vre
becam
major
problem
nosocomi
pathogen
antibiot
pressur
deriv
fi
rst
widespread
use
thirdgener
cephalosporin
antibiot
hospit
often
cite
major
factor
emerg
mrsa
coemerg
nosocomi
pathogen
mrsa
methicillinresist
coagulaseneg
staphylococci
becom
lead
caus
ivdrel
bsi
prosthesisrel
surgic
site
infect
earli
vre
burst
onto
hospit
icu
scene
unit
state
within
year
becam
entrench
tertiari
medic
center
heavi
use
vancomycin
often
empir
treatment
respons
concern
mrsa
probabl
initi
factor
drive
emerg
vre
set
howev
exposur
cephalosporin
antimicrobi
antianaerob
activ
emerg
greatest
risk
factor
nosocomi
colon
infect
vre
wit
grow
problem
resist
fungi
shift
noncandida
albican
speci
repres
effect
heavi
empir
use
azol
fl
uconazol
hospit
period
icu
compon
cdc
nni
system
power
reaffi
rm
rapidli
rise
rate
bacteri
resist
us
icu
past
year
see
fig
larg
extent
emerg
antimicrobi
resist
refl
ect
combin
effect
genet
select
antibiot
pressur
frequenc
crossinfect
icu
resist
mechan
eg
extendedspectrum
esbl
confer
resist
thirdgener
cephalosporin
ceftazidim
shift
singl
amino
acid
exist
resist
gene
lead
new
inactiv
enzym
resist
bacteria
penicillinresist
pneumococci
multipl
resist
gene
must
cobbl
togeth
specifi
c
exact
sequenc
may
take
year
evolv
emerg
spread
antibiot
pressur
provid
necessari
darwinian
forc
amplifi
genet
chang
usual
resist
emerg
specifi
c
agent
use
heavili
henc
provid
greatest
pressur
instanc
genet
linkag
resist
mechan
unrel
class
antimicrobi
result
capac
heavi
use
one
drug
class
select
resist
differ
class
exampl
use
trimethoprimsulfamethoxazol
associ
statist
emerg
ceftazidimeresist
e
coli
k
pneumonia
result
linkag
singl
plasmid
gene
encod
product
esbl
trimethoprimsulfamethoxazol
resist
larg
proport
extendedspectrum
produc
gramneg
bacilli
also
resist
fl
uoroquinolon
epidemiolog
clinic
studi
antibiot
resist
alway
proport
patient
resist
found
without
exposur
problem
antibiot
patient
usual
import
risk
factor
increas
sever
underli
diseas
extrem
age
presenc
invas
devic
recent
surgeri
proxim
patient
infect
colon
antibioticresist
bacteria
case
presenc
antibioticresist
strain
often
consequ
patienttopati
spread
usual
contamin
hand
hcw
occasion
spread
result
contamin
common
sourc
inadequ
clean
piec
equip
studi
hcw
hand
hygien
show
rate
handwash
patient
contact
rang
best
inadequ
control
resist
especi
icu
staff
extrem
busi
less
like
attent
hand
hygien
stem
tide
antimicrobi
resist
requir
multifacet
approach
see
box
especi
icu
antibiot
pressur
laps
hospit
hygien
usual
greatest
first
activ
surveil
resist
bacteria
essenti
provid
understand
local
problem
need
support
surveil
treatment
cultur
must
obtain
suspect
site
infect
empir
antibiot
therapi
initi
benefi
routin
surveil
cultur
eg
period
cultur
sputum
specimen
rectal
swab
assess
rate
colon
resist
bacteria
icu
depend
cultur
use
second
rate
resist
begin
increas
molecular
type
pulsedfi
eld
gel
electrophoresi
differenti
spread
singl
strain
clonal
expans
suggest
persontoperson
common
sourc
transmissionfrom
spread
multipl
strain
polyclon
expans
suggest
emerg
resist
individu
patient
result
antibiot
pressur
exogen
introduct
multipl
resist
strain
often
problemsclon
polyclonalcoexist
third
import
hand
hygien
must
stress
time
aggress
hand
hygien
campaign
adher
monitor
feedback
ward
even
individu
result
may
achiev
complianc
rate
high
situat
eg
larg
resist
iceberg
extens
patient
colon
antibiot
resist
bacteria
level
adher
may
suffi
cient
control
crossinfect
respons
problem
encourag
univers
glove
addit
wider
use
alcoholbas
hand
rub
beltandsuspend
approach
bridg
gap
left
incomplet
attent
hand
hygien
even
best
circumst
use
univers
glove
success
control
spread
aminoglycosideresist
gramneg
bacilli
icu
c
diffi
cilerel
diarrhea
patient
intact
skin
environ
patient
room
may
sourc
resist
bacteria
vre
recommend
dispos
examin
glove
worn
contact
icu
patient
environ
glove
total
barrier
must
remov
hand
disinfect
alcohol
hand
rub
patient
contact
fourth
antimicrobi
stewardship
essenti
see
tabl
primari
goal
antimicrobi
stewardship
optim
clinic
outcom
minim
unintend
consequ
antimicrobi
use
toxic
emerg
resist
c
diffi
cileassoci
diarrhea
antimicrobi
use
drive
antimicrobi
resist
frequenc
inappropri
antimicrobi
use
use
surrog
marker
antimicrobi
resist
antimicrobi
stewardship
comprehens
infect
control
program
essenti
limit
emerg
transmiss
antimicrobialresist
pathogen
studi
assess
util
antimicrobi
stewardship
focus
adult
icu
burden
antimicrobi
resist
greatest
comprehens
evidencebas
stewardship
program
combat
antimicrobi
resist
typic
multifacet
multidisciplinari
program
size
complex
manag
team
specifi
c
measur
appli
optim
prescrib
vari
basi
local
antimicrobi
use
pattern
resist
trend
avail
resourc
two
core
strategi
provid
foundat
success
antimicrobi
stewardship
program
prospect
audit
intervent
feedback
formulari
restrict
preauthor
sever
studi
shown
prospect
audit
antimicrobi
use
intervent
feedback
effect
mean
reduc
inappropri
antimicrobi
use
random
trial
conduct
tertiari
teach
hospit
inpati
receiv
parenter
antimicrobi
therapi
random
intervent
group
receiv
suggest
optim
antimicrobi
use
infecti
diseas
physician
intervent
physician
intervent
group
implement
suggest
receiv
result
fewer
day
parenter
therapi
save
per
patient
similar
result
note
trial
undertaken
commun
hospit
daili
review
antimicrobi
use
feasibl
review
antimicrobi
usag
day
week
may
still
signifi
cant
impact
effect
audit
intervent
feedback
undertaken
easili
autom
comput
surveil
antimicrobi
use
allow
target
specifi
c
unit
problem
greatest
formulari
restrict
preauthor
requir
specifi
c
agent
common
hospit
antimicrobi
restrict
unequivoc
effect
method
control
antimicrobi
use
howev
unclear
whether
antimicrobi
restrict
achiev
import
outcom
reduc
antimicrobi
resist
sever
studi
outbreak
c
diffi
cileassoci
diarrhea
shown
abrupt
cessat
outbreak
follow
restrict
greatli
reduc
use
one
key
antimicrobi
clindamycin
thirdgener
cephalosporin
howev
studi
document
inexor
rise
resist
rate
nosocomi
pathogen
despit
rigor
program
antimicrobi
restrict
one
explan
increas
resist
may
compensatori
increas
usag
broadspectrum
antimicrobi
restrict
agent
thu
counteract
benefi
restrict
furthermor
restrict
use
singl
drug
reduc
antimicrobi
resist
may
ineffect
crossresist
bacteri
speci
one
class
antimicrobi
rule
nosocomi
organ
one
core
strategi
adopt
supplement
close
collabor
among
core
antimicrobi
stewardship
team
infect
control
personnel
health
care
provid
hospit
administr
beyond
two
major
mechan
antimicrobi
stewardship
mention
earlier
element
incorpor
institut
antimicrobi
stewardship
program
includ
educ
health
care
provid
howev
passiv
educ
effort
confer
present
teach
session
provis
guidelin
margin
effect
absenc
activ
intervent
clinic
practic
guidelin
introduc
increas
frequenc
howev
impact
guidelin
provid
behavior
clinic
outcom
diffi
cult
measur
guidelin
tailor
local
antimicrobi
resist
pattern
antimicrobi
use
trend
may
impact
gener
clinic
pathway
interest
spark
icu
reborn
concept
antibiot
cycl
recent
experi
evalu
switch
therapi
empir
antibiot
use
rather
actual
cycl
shown
benefi
cial
reduct
resist
among
gramneg
bacilli
preval
vre
approach
well
true
cycl
differ
antimicrobi
class
may
effect
limit
period
close
environ
icu
transient
reduc
select
pressur
thu
resist
restrict
agent
yet
studi
thu
far
shown
consist
longterm
benefi
cycl
mathemat
model
predict
cycl
effect
measur
reduc
antimicrobi
resist
antimicrobi
order
form
reduc
antimicrobi
usag
use
automat
stop
order
requir
physician
justifi
cation
streamlin
deescal
therapi
base
cultur
data
essenti
compon
appropri
antimicrobi
use
studi
show
substanti
reduct
day
antimicrobi
use
cost
save
comput
order
entri
provid
need
inform
moment
neutral
nonjudgment
factbas
format
system
effi
cient
well
accept
hold
promis
chang
prescrib
behavior
materi
effect
antimicrobi
stewardship
program
fi
nancial
selfsupport
improv
patient
care
studi
shown
reduct
antimicrobi
usag
annual
save
larger
teach
hospit
commun
hospit
recent
guidelin
infecti
diseas
societi
america
societi
healthcar
epidemiolog
america
provid
detail
recommend
develop
institut
program
antimicrobi
stewardship
summar
tabl
intens
interest
arisen
europ
unit
state
use
select
digest
decontamin
sdd
prevent
bacteri
pneumonia
nosocomi
infect
mechan
ventil
icu
patient
novel
therapi
base
premis
upper
respiratori
tract
fl
ora
exist
continuum
gastrointestin
fl
ora
mucos
microorgan
make
major
reservoir
pathogen
caus
pneumonia
mani
nosocomi
infect
especi
mechan
ventil
patient
ventil
icu
patient
nasogastr
tube
provid
direct
conduit
refl
ux
microorgan
heavili
colon
stomach
oropharynx
organ
gain
access
lower
respiratori
tract
sdd
consist
four
compon
broadspectrum
parenter
antibiot
given
approxim
day
treat
infect
incub
time
admiss
icu
topic
antimicrobi
usual
polymyxin
e
tobramycin
amphotericin
b
period
appli
oropharynx
instil
gut
variabl
period
usual
entir
durat
icu
stay
reduc
mucos
burden
gramneg
bacteria
yeast
preserv
anaerob
fl
ora
reemphas
adher
hand
hygien
prevent
nosocomi
transmiss
bacteria
european
center
empir
barrier
isol
serial
surveil
cultur
oropharynx
rectum
monitor
efficaci
treatment
eleven
metaanalys
assess
effi
caci
sdd
reduc
infect
mortal
publish
tabl
found
reduct
pneumonia
found
reduc
mortal
howev
recent
review
show
result
metaanalys
invers
relat
studi
design
case
sdd
may
overestim
effi
caci
studi
metaanalys
sdd
make
distinct
parenter
topic
sdd
metaanalys
undertook
subgroup
analys
found
topic
antibiot
alon
reduc
infect
mortal
greatest
deterr
widespread
accept
sdd
fear
promot
emerg
spread
antimicrobi
resist
microorgan
antibiot
pressur
without
question
singl
power
forc
drive
select
resist
microorgan
strategi
prevent
infect
icu
potenti
increas
infect
caus
multiresist
organ
must
approach
cautious
number
studi
underli
concern
promot
antimicrobi
resist
sdd
numer
studi
document
major
shift
microbi
ecolog
icu
use
sdd
studi
lingnau
colleagu
year
sdd
ciprofl
oxacin
led
mark
increas
mrsa
infect
ciprofl
oxacinresist
aureu
number
infect
caus
multiresist
bacteria
acinetobact
also
increas
sdd
distinct
must
also
made
risk
individu
receiv
sdd
infect
caus
resist
pathogen
institut
risk
increas
preval
antimicrobialresist
organ
relat
use
sdd
although
consequ
undesir
given
skyrocket
rate
endem
nosocomi
mrsa
vre
infect
worldwid
anyhowev
smallpotenti
increas
antimicrobi
resist
must
taken
serious
order
better
address
issu
welldesign
clusterrandom
trial
employ
multilevel
model
specifi
calli
address
effect
sdd
antimicrobi
resist
across
entir
spectrum
microbi
pathogen
institut
level
necessari
data
avail
believ
continu
north
american
concern
effect
sdd
antimicrobi
resist
justifi
ed
particularli
institut
mrsa
vre
endem
encompass
virtual
larger
hospit
given
effect
measur
prevent
nosocomi
infect
exist
believ
sdd
restrict
select
patient
certain
trauma
patient
potenti
adjunct
control
measur
nosocomi
outbreak
caus
multipli
resist
organ
recent
random
trial
identifi
ed
sever
novel
measur
prevent
vap
semirecumb
posit
subglott
suction
endotrach
tube
believ
approach
ecolog
attract
control
measur
ventil
icu
patient
prophylact
topic
system
antibiot
fewer
patient
room
improv
facil
handwash
use
cohort
nurs
ie
assign
nurs
design
patient
reduc
incid
endem
nosocomi
infect
neonat
pediatr
icu
complic
form
protect
isol
reduc
high
rate
nosocomi
infect
patient
profound
granulocytopenia
fullthick
burn
moreov
routin
use
gown
glove
special
pediatr
unit
associ
mark
declin
incid
nosocomi
infect
rsv
routin
use
glove
patient
contact
shown
reduc
incid
nosocomi
c
diffi
cile
infect
nearli
fi
vefold
larg
veteran
hospit
unfortun
studi
prospect
evalu
protect
isol
icu
patient
perform
newborn
pediatr
patient
yield
confl
ict
gener
disappoint
result
howev
studi
major
weak
design
recent
sever
studi
shown
preemptiv
use
barrier
precaut
effect
reduc
spread
multiresist
organ
mrsa
vre
epidem
endem
set
tabl
colon
nosocomi
organ
could
prevent
least
delay
invas
devic
remov
incid
infect
might
signifi
cantli
reduc
one
major
prospect
trial
assess
effi
caci
simpl
protect
isolationwhich
prefer
call
preemptiv
barrier
precautionsto
reduc
incid
nosocomi
infect
pediatr
intens
care
studi
highrisk
children
month
immunosuppress
requir
prolong
mechan
ventilatori
support
exposur
invas
devic
pediatr
icu
random
receiv
standard
care
without
special
precaut
preemptiv
barrier
isol
use
dispos
nonwoven
polypropylen
gown
nonsteril
latex
glove
patient
contact
risk
factor
predispos
patient
infect
compar
two
group
nosocomi
colon
occur
later
among
isol
patient
median
versu
day
associ
subsequ
infect
patient
compar
patient
given
standard
care
among
children
isol
interv
fi
rst
infect
significantli
longer
median
versu
day
daili
infect
rate
twofold
lower
versu
infect
per
icu
day
fewer
day
fever
benefi
isol
notabl
day
icu
care
isol
well
toler
patient
famili
unannounc
monitor
show
children
group
touch
handl
indiscern
hospit
personnel
famili
studi
conclud
use
dispos
highbarri
gown
glove
care
select
highrisk
children
requir
prolong
icu
care
substanti
reduc
incid
nosocomi
infect
well
toler
compromis
deliveri
care
simpl
form
protect
isol
gener
control
measur
would
also
seem
prefer
attempt
suppress
nosocomi
colon
sdd
studi
necessari
determin
cost
effect
prophylact
barrier
precaut
icu
especi
effi
caci
protect
isol
adult
surgic
icu
incid
nosocomi
infect
high
studi
also
determin
rel
import
wear
gown
compar
wear
glove
alon
patient
prolong
sever
granulocytopenia
receiv
high
dosag
corticosteroid
usual
part
immunosuppress
regimen
prevent
transplant
reject
risk
invas
pulmonari
infect
caus
aspergillu
speci
zygomycet
fi
lament
airborn
fungi
associ
high
mortal
risk
invas
infect
appear
directli
relat
count
airborn
fungi
numer
outbreak
link
build
construct
failur
aircontrol
system
studi
shown
isol
vulner
patient
positivepressur
room
sporefre
hepafi
ltere
air
greatli
reduc
risk
invas
infect
hepafi
ltere
icu
room
avail
care
patient
receiv
bone
marrow
solid
organ
transplant
requir
intens
care
especi
earli
posttranspl
period
treatment
reject
dosag
immunosuppress
drug
high
preemptiv
use
barrier
isol
precaut
gown
glove
provid
dedic
patient
care
item
stethoscop
sphygmomanomet
highrisk
patient
time
admiss
simpl
effect
strategi
prevent
hcw
acquir
hand
contamin
multiresist
organ
contact
patient
unrecogn
colon
infect
block
transmiss
yet
uncolon
patient
note
earlier
nosocomi
epidem
occur
icu
epidem
suspect
epidemiolog
approach
must
method
thorough
yet
expediti
direct
toward
establish
bona
fi
de
natur
put
epidem
infect
ie
rule
pseudoinfect
confi
rming
exist
epidem
ie
rule
pseudoepidem
defi
ning
reservoir
mode
transmiss
epidem
pathogen
importantli
control
epidem
quickli
complet
control
measur
predic
accur
delin
epidemiolog
epidem
pathogen
hospit
infect
control
committe
must
prepar
administr
carri
investig
implement
need
control
measur
essenti
step
deal
suspect
outbreak
nosocomi
bloodstream
infect
review
previous
box
illustr
approach
nosocomi
epidem
epidemiolog
investig
unusu
complic
outbreak
infusionrel
bacteremia
review
period
late
march
three
patient
univers
hospit
develop
primari
nosocomi
bacteremia
similar
nonfer
gram
fig
becam
bacterem
hour
oper
bloodstream
pathogen
case
shown
pseudomona
pickettii
biovari
organ
also
cultur
intraven
fl
uid
two
patient
time
serendipit
outbreak
adult
patient
hospit
receiv
intraven
fl
uid
particip
studi
intra
week
surgeri
avail
reconfi
rmation
subtyp
p
pickettii
biovari
isol
intraven
fl
uid
three
probabl
case
januari
avail
retest
consid
like
also
p
pickettii
biovari
review
result
biochem
test
common
three
six
confi
rmed
isol
administr
prepared
immedi
retriev
put
epidem
isol
confi
rmation
ident
speci
subtyp
one
method
part
studi
protocol
specimen
routin
obtain
patient
intraven
fl
uid
cathet
remov
review
nearli
cultur
intraven
fl
uid
infus
particip
studi
sinc
outset
month
earlier
show
three
addit
surgic
patient
oper
march
intraven
fl
uid
cultur
posit
p
pickettii
biovari
see
fig
even
though
none
shown
clinic
sign
bacteremia
molecular
subtyp
restrict
enzym
digest
pulsedfi
eld
electrophoresi
delin
restrict
polymorph
pattern
show
six
isol
clonal
three
patient
oper
januari
intraven
fl
uid
cultur
posit
similar
nonfer
gramneg
bacillu
although
three
isol
longer
avail
result
screen
biochem
panel
api
analytab
inc
time
ident
six
patient
p
pickettii
contamin
intraven
fl
uid
without
associ
bacteremia
three
septic
patient
multipl
posit
blood
cultur
clinic
septic
shock
p
pickettii
isol
local
site
infect
urinari
tract
lower
respiratori
tract
surgic
wound
patient
review
nosocomi
bacteremia
past
year
show
p
pickettii
previous
identifi
ed
posit
blood
cultur
institut
indic
cluster
three
case
six
instanc
contamin
infus
without
bacteremia
repres
true
epidem
result
subtyp
common
sourc
epidem
cdc
manufactur
contact
none
nni
hospit
report
p
pickettii
bacteremia
past
year
manufactur
never
identifi
ed
contamin
p
pickettii
qualiti
control
microbiolog
sampl
fentanyl
distribut
receiv
complaint
user
suspect
contamin
fentanyl
moreov
survey
surround
wisconsin
hospit
also
use
manufactur
fentanyl
reveal
none
experienc
nosocomi
bacteremia
p
pickettii
casecontrol
studi
compar
case
recent
surgeri
oper
patient
neg
intraven
fl
uid
cultur
intraven
dress
studi
tabl
show
case
oper
control
case
receiv
fentanyl
intraven
oper
room
p
mean
total
dose
given
case
far
greater
given
control
patient
receiv
drug
versu
p
hospit
time
fentanyl
use
oper
room
part
balanc
anesthesia
drug
receiv
ampul
manufactur
week
one
three
pharmaci
technician
rotat
drew
steril
syring
fentanyl
like
need
follow
week
oper
room
day
one
technician
deliv
enough
predrawn
syring
oper
room
meet
need
case
done
day
cultur
predrawn
fentanyl
syring
central
pharmaci
prompt
fi
nding
casecontrol
studi
show
twenti
fi
fti
syring
sampl
contamin
p
pickettii
concentr
greater
cfuml
none
thirtyfi
syring
show
contamin
p
extens
cultur
within
central
pharmaci
neg
evid
environment
contamin
p
pickettii
one
except
p
pickettii
biovari
ident
antimicrobi
suscept
pattern
restrict
enzym
fragment
pattern
epidem
strain
recov
blood
cultur
patient
intraven
infus
cultur
concentr
cfu
ml
fi
specimen
distil
water
drawn
tap
central
pharmaci
epidem
strain
shown
multipli
well
fentanyl
solut
attain
concentr
exceed
cfuml
within
hour
second
casecontrol
studi
suggest
strongli
epidem
caus
theft
fentanyl
syring
one
pharmaci
staff
member
replac
distil
water
individu
thought
steril
unfortun
contamin
p
pickettii
pharmaci
member
resign
earli
investig
longer
work
hospit
april
hospit
system
provid
fentanyl
narcot
oper
room
chang
narcot
longer
predrawn
syring
central
pharmaci
deliv
oper
room
unopen
vial
ampul
anesthesiologist
order
narcot
fi
lled
staff
pharmacist
assign
oper
room
bacteremia
p
pickettii
occur
sinc
march
see
fig
cultur
sampl
hospit
patient
intraven
fl
uid
research
studi
sinc
shown
contamin
p
pickettii
outbreak
illustr
power
genet
subtyp
casecontrol
analys
identifi
caus
epidem
illustr
potenti
contamin
parenter
drug
admixtur
extraordinari
rang
epidemiolog
mechan
nosocomi
bloodstream
infect
deriv
contamin
epidemiolog
microbiolog
studi
suggest
indic
intrins
contamin
wide
distribut
commerci
product
devic
local
state
health
author
us
food
drug
administr
cdc
manufactur
inform
immedi
remain
product
quarantin
retain
evalu
public
health
author
hcw
gener
especi
work
icu
expos
daili
critic
ill
patient
mani
contagi
undiagnos
infect
increas
risk
acquir
occup
relat
infect
includ
tuberculosi
herp
simplex
viru
infect
chickenpox
cytomegaloviru
infect
hepat
b
c
hiv
infect
infl
uenza
measl
rubella
mump
pertussi
viral
conjunct
fortun
risk
pose
mani
infect
elimin
immun
hcw
advisori
committe
immun
practic
acip
last
made
recommend
vaccin
hcw
howev
number
new
develop
vaccineprevent
diseas
emerg
sinc
guidelin
last
publish
consider
number
occup
infect
exist
current
vaccin
hospit
mandat
jcaho
must
employe
health
servic
written
protocol
manag
biohazard
exposur
box
protocol
permit
expediti
comprehens
evalu
time
administr
postexposur
prophylaxi
pep
antiretrovir
hiv
exposur
immun
serum
globulin
hepat
b
immun
globulin
exposur
hepat
b
antimicrobi
prophylaxi
exposur
contagi
bacteri
pathogen
neisseria
meningitidi
bordetella
pertussi
singl
greatest
measur
hospit
take
reduc
risk
biohazard
exposur
implement
comprehens
program
activ
monitor
occup
exposur
educ
hcw
consequ
way
prevent
exposur
advoc
rigor
evalu
new
safeti
technolog
mean
reduc
exposur
import
uncompromis
complianc
univers
precaut
protect
hcw
unknow
exposur
hiv
bloodborn
virus
discuss
importantli
greatest
emphasi
train
univers
precaut
place
measur
prevent
needl
stick
sharp
injuri
prohibit
recap
use
needl
make
impervi
needl
dispos
contain
avail
bedsid
icu
patient
use
engin
control
needleless
system
hold
greatest
promis
effect
materi
reduct
hazard
sharp
injuri
percutan
exposur
unvaccin
hcw
blood
patient
hepat
b
surfac
antigen
hbsag
posit
carri
consider
risk
seroconvers
develop
clinic
diseas
risk
greatli
magnifi
ed
sourc
patient
hepat
b
e
antigen
hbeag
posit
risk
seroconvers
risk
develop
clinic
diseas
introduct
recombin
hepat
b
vaccin
greatli
reduc
risk
occup
acquir
diseas
recommend
hcw
receiv
complet
seri
immun
month
furthermor
acip
recommend
hcw
document
protect
serum
titer
hepat
b
surfac
antibodi
hbsab
serum
titer
iuml
month
complet
primari
seri
hcw
mount
protect
titer
undergo
secondari
immun
seri
hcw
expos
hepat
b
develop
protect
titer
primari
secondari
immun
seri
complet
primari
immun
seri
given
postexposur
prophylaxi
pep
detail
us
public
health
servic
report
case
measl
mump
rubella
declin
steadili
unit
state
sinc
introduct
mandatori
childhood
immun
howev
epidem
measl
recent
mump
continu
problem
mani
part
countri
sever
measl
suscept
hcw
expos
addit
patient
incub
phase
infect
well
describ
literatur
result
recommend
hcw
born
document
immun
measl
rubella
either
laboratori
evid
protect
titer
physician
document
clinic
measl
rubella
document
appropri
vaccin
measl
rubella
although
acip
less
stringent
regard
document
immun
mump
recommend
hcw
receiv
trival
measl
mump
rubella
mmr
vaccin
rather
singl
vaccin
nonimmun
hcw
expos
measl
pep
mmr
vaccin
shown
reduc
likelihood
develop
fulmin
diseas
measl
immunoglobulin
anoth
pep
option
nonimmun
hcw
contraind
immunizationpregnancybut
provid
temporari
protect
recap
resheath
use
needl
must
strongli
discourag
except
rare
circumst
permit
immedi
dispos
case
cap
must
done
use
onehand
techniqu
special
sheath
medic
nurs
personnel
must
appris
import
obtain
adequ
assist
administ
inject
infus
therapi
patient
may
abl
cooper
personnel
must
appris
need
use
extrem
care
clean
procedur
involv
needl
sharp
lumbar
punctur
thoracentesi
central
venou
cathet
placement
strong
institut
commit
continu
evalu
select
adopt
technologybas
approach
prevent
sharp
injuri
greatest
impact
accident
sharp
injuri
unless
injuri
occur
clean
sharp
use
patient
injuri
immedi
report
employe
health
servic
workrel
injuri
gener
evalu
manag
consist
inexpens
surveil
workrel
injuri
assist
mechan
ensur
prompt
manag
biohazard
injuri
hour
day
includ
night
weekend
emerg
depart
personnel
train
institut
biohazard
injuri
protocol
must
avail
hospit
personnel
render
care
servic
patient
includ
staff
physician
hous
offic
health
care
student
cover
institut
servic
ensur
consist
report
treatment
injuri
employe
health
servic
personnel
meet
employe
sustain
biohazard
injuri
ascertain
exact
reason
accid
review
prevent
similar
injuri
futur
particular
attent
given
hcw
sustain
repeat
injuri
identifi
accidentpron
activ
individu
highrisk
work
situat
modifi
ed
occup
acquisit
varicellazost
viru
vzv
well
describ
transmiss
rate
among
suscept
hcw
rang
publish
studi
infect
hcw
pose
threat
transmiss
suscept
patient
hcw
compar
person
acquir
varicella
adolesc
often
experi
sever
diseas
particularli
pregnant
hcw
ask
histori
primari
varicella
absenc
posit
histori
hcw
undergo
serolog
test
confi
rm
seroposit
immun
live
attenu
vaccin
suscept
hcw
care
patient
suspect
confi
rmed
varicella
zoster
infect
particularli
pregnant
event
accident
exposur
suscept
hcw
undergo
varicella
immun
within
hour
exposur
basi
studi
demonstr
reduc
risk
develop
clinic
infect
attenu
clinic
diseas
routin
use
varicellazost
immun
globulin
vzig
pep
suscept
hcw
expos
vzv
recommend
rather
decis
administ
vzig
guid
presenc
risk
factor
increas
risk
sever
diseas
eg
pregnanc
immunodefi
cient
condit
advanc
aid
infl
uenza
respons
hospit
death
unit
state
year
nosocomi
outbreak
infl
uenza
common
serv
put
hcw
consider
risk
acquir
transmit
infl
uenza
other
outbreak
impos
consider
econom
burden
health
care
institut
increas
advers
event
among
hcw
patient
alik
infl
uenza
immun
hcw
signifi
cantli
reduc
day
febril
ill
sick
leav
random
control
trial
survey
suggest
hcw
tend
view
infl
uenza
immun
mean
protect
ill
howev
accumul
evid
suggest
infl
uenza
immun
hcw
also
signifi
cantli
reduc
rate
infl
uenzarel
morbid
mortal
among
potenti
expos
patient
varieti
health
care
set
moreov
expand
infl
uenza
rate
hcw
shown
cost
save
institut
perspect
despit
evid
voluntari
immun
rate
among
us
hcw
remain
disappointingli
lowin
rang
reason
expert
begin
call
mandatori
infl
uenza
immun
hcw
ie
condit
employ
much
way
hepat
b
mmr
vaccin
mandatori
hcw
hospit
hcw
increas
risk
develop
pertussi
result
wane
immun
adulthood
numer
pertussi
epidem
among
hcw
report
recent
year
pertussi
outbreak
associ
consider
econom
consequ
studi
shown
routin
provid
pertussi
booster
hcw
form
tetanu
toxoid
reduc
diphtheria
toxoid
acellular
pertussi
adsorb
vaccin
tdap
cost
effect
nation
foundat
infecti
diseas
nfid
acip
recommend
hcw
undergo
booster
immun
tdap
although
recommend
yet
endors
us
depart
health
human
servic
primari
hsv
paronychia
long
occup
hazard
icu
nurs
physician
usual
associ
great
deal
pain
discomfort
fever
lymphaden
leav
work
week
uncommon
one
compel
reason
icu
hcw
routin
wash
hand
contact
icu
patient
wear
glove
contact
patient
airwayinclud
glove
hand
tracheal
suctioningi
protect
miser
condit
numer
report
tuberculosi
tb
outbreak
hospit
health
care
set
earli
remind
health
care
commun
risk
associ
care
patient
activ
pulmonari
tuberculosi
featur
common
outbreak
failur
recogn
patient
activ
pulmonari
tuberculosi
import
measur
prevent
transmiss
tuberculosi
rapidli
identifi
isol
patient
suspect
tuberculosi
promptli
initi
appropri
therapi
tuberculosi
confi
rmed
reduc
durat
infecti
updat
guidelin
prevent
nosocomi
tb
recent
publish
stress
import
administr
environment
person
respiratori
protect
control
implement
recommend
led
remark
reduct
nosocomi
transmiss
rate
nearli
million
person
unit
state
infect
hepat
c
viru
hcv
respons
death
everi
year
although
alreadi
high
rise
preval
hcv
infect
popul
potenti
expos
hcw
occup
acquir
infect
studi
fail
fi
nd
higher
seropreval
hcv
among
hcw
gener
popul
howev
least
one
studi
found
previou
histori
needl
stick
injuri
associ
increas
risk
hcv
infect
pool
analys
publish
studi
suggest
seroconvers
rate
follow
percutan
injuri
involv
hcvposit
person
risk
similar
seen
percutan
injuri
involv
needl
stick
exposur
hiv
current
guidelin
manag
hcw
expos
hcv
recommend
serolog
test
measur
serum
alanin
aminotransferas
alt
level
without
hcv
pcr
test
baselin
month
later
make
specifi
c
treatment
recommend
howev
recommend
may
undergo
modifi
cation
near
futur
light
studi
demonstr
sustain
virolog
respons
interferon
monotherapi
excess
patient
acuteonset
hcv
infect
human
immunodefi
cienci
viru
although
risk
occup
acquir
hiv
infect
low
zero
probabl
addit
possibl
case
occup
acquir
hiv
unit
state
vast
major
involv
percutan
injuri
hollowbor
needl
contamin
blood
type
sharp
injuri
less
like
transmit
hiv
singl
document
case
occup
hiv
transmiss
caus
bodi
fl
uid
exposur
bloodbloodi
pleural
fl
uidha
report
literatur
although
random
trial
exist
consider
data
anim
observ
studi
suggest
pep
antiretrovir
signifi
cantli
reduc
likelihood
hiv
transmiss
follow
highrisk
exposur
reason
us
public
health
servic
issu
detail
recommend
occup
hiv
pep
choic
number
drug
driven
characterist
hcw
type
exposur
characterist
sourc
patient
clearli
nosocomi
infect
one
import
caus
iatrogen
morbid
mortal
patient
requir
prolong
lifesupport
care
icu
much
learn
past
decad
rel
risk
especi
pathogenesi
epidemiolog
infect
inform
provid
scientifi
c
underpin
prevent
strategi
prove
effect
howev
urgent
need
better
research
prevent
nosocomi
infect
icu
patient
box
particularli
respect
strategi
prevent
colon
multiresist
microorgan
prevent
infect
even
colon
alreadi
occur
understand
epidemiolog
nosocomi
infect
especi
icu
base
studi
epidem
welldesign
studi
necessari
better
defi
ne
epidemiolog
endem
nosocomi
infect
especi
caus
resist
staphylococci
enterococci
gramneg
bacilli
yeast
import
hand
carriag
pathogen
hospit
personnel
role
airborn
transmiss
icu
relev
contamin
inanim
hospit
environ
resist
pathogen
need
better
delin
well
factor
infl
uenc
nosocomi
colon
superinfect
resist
bacteria
yeast
addit
larger
sophist
studi
use
multivari
techniqu
statist
analysi
defi
ne
risk
factor
major
form
nosocomi
infect
icu
necessari
guid
alloc
infect
control
resourc
target
futur
research
effort
consid
period
greatli
increas
suscept
infect
icu
patient
limiteduntil
invas
devic
removeda
major
commit
must
made
devis
evalu
strategi
block
transmiss
organ
patient
prevent
least
delay
nosocomi
colon
one
oldest
yet
import
infect
control
measureshand
hygienei
still
done
almost
indiffer
hcw
hospit
includ
within
icu
innov
approach
necessari
improv
frequenc
qualiti
handwash
patient
contact
like
result
acquisit
nosocomi
organ
exactli
hand
wash
maxim
benefi
agent
question
pose
could
frequent
handwash
approach
time
per
shift
neonat
icu
increas
potenti
transmiss
microorgan
methicillinresist
coagulaseneg
staphylococci
frequenc
handwash
well
agent
use
critic
reexamin
beyond
certain
frequenc
may
necessarili
better
handwash
machin
substanti
augment
degerm
adopt
wide
could
regular
applic
chlorhexidinecontain
evapor
lotion
use
without
water
replac
convent
handwash
least
compens
suboptim
handwash
current
practic
larg
clinic
trial
ideal
multipl
center
necessari
ascertain
effi
caci
lack
effi
caci
innov
approach
hand
degerm
reduc
infect
highrisk
patient
particularli
nurseri
icu
wherea
sdd
topic
nonabsorb
antibiot
shown
promis
prevent
nosocomi
respiratori
infect
icu
patient
note
potenti
effect
microbi
ecolog
icu
must
view
caution
costbenefi
longterm
effect
sdd
need
better
clarifi
cation
use
simpl
barrier
precaut
prevent
colon
infect
shown
promis
warrant
studi
especi
icu
studi
shown
use
dedic
intraven
therapi
team
consist
train
nurs
technician
ensur
high
level
asept
techniqu
cathet
insert
followup
care
cathet
associ
greatli
reduc
rate
catheterrel
infect
appear
cost
effect
use
team
train
icu
personnel
insert
urethr
cathet
provid
followup
care
cathet
intravascular
devic
percutan
tube
icu
deserv
studi
remark
compar
clinic
trial
variou
chemic
antisept
avail
disinfect
skin
insert
intravascular
devic
assist
surgeri
studi
antisept
handwash
agent
larg
random
clinic
trial
ideal
multipl
center
necessari
infect
rather
box
studi
better
defi
ne
epidemiolog
endem
nosocomi
infect
especi
caus
resist
staphylococci
gramneg
bacilli
candida
relev
hand
carriag
pathogen
hospit
personnel
role
airborn
transmiss
rel
import
contamin
inanim
hospit
environ
especi
methicillinresist
aureu
c
diffi
cile
resist
organ
biolog
factor
infl
uenc
colon
nosocomi
organ
factor
govern
superinfect
resist
bacteria
candida
better
understand
risk
factor
predispos
infect
especi
icu
guid
alloc
resourc
infect
control
focu
research
effort
innov
strategi
prevent
nosocomi
colon
interrupt
crossinfect
especi
icu
new
approach
improv
complianc
improv
effect
handwash
patient
variou
type
barrier
precaut
form
protect
isol
true
effi
caci
costbenefi
select
digest
decontamin
ecolog
effect
longterm
use
must
assess
care
dedic
devicecar
team
larg
random
clinic
trial
variou
cutan
antisept
avail
infect
rather
colon
index
comparison
handwash
personnel
site
disinfect
invas
devic
patient
bath
decolon
research
devic
innov
design
implicitli
reduc
contamin
colonizationresist
polym
possibl
incorpor
antimicrobi
onto
surfac
polym
better
techniqu
use
enhanc
safeti
costeffect
needleless
system
protect
health
care
personnel
improv
laboratori
test
identifi
infect
accur
rapidli
especi
tracheobronch
pneumonia
reduc
unnecessari
antibiot
therapi
yet
permit
earli
therapi
avert
progress
lifethreaten
sepsi
measur
restrict
improv
use
antibiot
especi
icu
expand
effect
approach
educ
infect
control
health
care
personnel
especi
physician
respect
handwash
use
isol
invas
devic
use
antibiot
modifi
ed
maki
dg
risk
factor
nosocomi
infect
intens
care
devic
vs
natur
goal
next
decad
arch
intern
med
cutan
colon
posit
cultur
use
index
comparison
consider
evid
indic
materi
use
construct
implant
devic
play
import
role
pathogenesi
devicerel
infect
name
whether
materi
provid
attract
surfac
adher
pathogen
microorgan
coagulaseneg
staphylococci
studi
necessari
delin
fulli
molecular
mechan
microbi
adher
prosthet
surfac
develop
new
materi
intrins
resist
colon
use
implant
devic
design
devic
intrins
deni
microbi
access
increas
use
diagnost
test
greatli
increas
awar
infecti
diseas
improv
laboratori
techniqu
identifi
infect
accur
rapidli
especi
method
reliabl
distinguish
colon
lower
respiratori
tract
earli
infect
merit
antimicrobi
therapi
could
greatli
reduc
unnecessari
antimicrobi
therapi
yet
detect
infect
earlier
progress
sepsi
multipleorgan
failur
antimicrobi
use
optim
icu
much
overus
hospit
particularli
extendedspectrum
penicillin
cephalosporin
imipenem
quinolon
antibiot
pressur
power
effect
hospit
microbi
ecolog
note
previous
profi
le
nosocomi
infect
especi
icu
must
better
last
certainli
least
mani
physician
remain
remark
oblivi
basic
precept
infect
control
nurs
gener
far
better
inform
effect
forc
ensur
complianc
infect
control
practic
effect
way
commun
essenti
inform
nosocomi
infect
control
hospit
personnel
especi
regard
handwash
asept
use
devic
antibiot
therapi
appli
consist
hospit
would
vast
immedi
benefi
ts
patient
modernday
icu
experi
rate
nosocomi
infect
three
fi
time
higher
nonicu
hospit
patient
rate
primari
bacteremia
nosocomi
pneumonia
time
higher
patient
sever
immunocompromis
critic
ill
high
sever
ill
score
substanti
increas
risk
nosocomi
infect
howev
nosocomi
infect
icu
appear
causal
directli
relat
lifesav
technolog
particularli
invas
devic
endotrach
tube
mechan
ventilatori
support
urethr
intravascular
cathet
intraventricular
cathet
facilit
colon
nosocomi
organ
greatli
increas
vulner
infect
major
reservoir
bacteri
nosocomi
pathogen
possibl
candida
well
icu
colon
infect
patient
infect
begin
nosocomi
colon
organ
acquir
hand
noncolon
hcw
increas
evid
suggest
antibioticresist
organ
particularli
mrsa
resist
enterococci
c
diffi
cile
may
also
acquir
inanim
environ
immedi
surround
patient
mycobacterium
tuberculosi
legionella
aspergillu
infl
uenza
viru
varicellazost
viru
measl
mump
new
highli
virul
sar
human
coronaviru
transmit
airborn
rout
icu
uniqu
conduc
epidem
spread
nosocomi
organ
type
especi
antibioticresist
bacteria
even
candida
half
hospit
epidem
occur
icu
activ
visibl
institut
infect
control
program
prevent
one
third
nosocomi
infect
surveil
infect
whether
total
focus
educ
personnel
essenti
compon
program
use
chlorhexidinecontain
agent
handwash
patient
reduc
endem
nosocomi
infect
icu
least
regular
use
waterless
alcoholcontain
hand
rub
gel
may
provid
compar
benefi
prevent
crossinfect
stringent
attent
isol
precaut
especi
dispos
glove
gown
contact
patient
known
infect
colon
resist
organ
mandatori
minim
crossinfect
prevent
outbreak
misus
glove
part
univers
precaut
may
paradox
increas
risk
nosocomi
infect
modernday
icu
must
adequ
number
special
negativepressur
isol
room
care
patient
suspect
proven
pulmonari
tuberculosi
airborn
infect
varicellazost
viru
patient
undergon
recent
bone
marrow
transplant
receiv
intens
chemotherapi
experienc
prolong
sever
granulocytopenia
receiv
icu
care
special
hepafi
ltere
positivepressur
isol
room
protect
devast
deep
aspergillu
fi
lament
fungal
infect
meticul
attent
asept
techniqu
use
maxim
barrier
precautionslongsleev
steril
surgic
gown
mask
head
cover
well
steril
glovesdur
insert
central
venou
cathet
use
chlorhexidin
solut
cutan
antisepsi
avoid
insert
femor
vein
prompt
remov
cathet
soon
longer
necessari
reduc
incid
catheterrel
bloodstream
infect
least
threefold
studi
suggest
prophylact
use
simpl
barrier
precaut
protect
isol
may
provid
protect
type
icuacquir
infect
protect
isol
appeal
ecolog
use
sdd
measur
avert
needl
stick
sharp
injuri
import
aspect
univers
precaut
measur
necessari
protect
hcw
hiv
bloodborn
virus
crisi
antibiot
resist
exist
icu
progress
increas
antibiot
resist
nosocomi
staphylococci
methicillin
gramneg
bacilli
aminoglycosid
expandedspectrum
betalactam
enterococci
vancomycin
ampicillin
sixfold
increas
candida
infect
past
decad
indic
highest
prioriti
reduc
antimicrobi
pressur
within
icu
novel
technolog
hold
greatest
promis
prevent
nosocomi
infect
gener
particularli
develop
medic
devic
intrins
resist
infect
identifi
effect
way
commun
knowledg
infect
control
hospit
personnel
especi
regard
handwash
asept
use
devic
antibiot
therapi
appli
consist
hospit
would
vast
immedi
benefi
ts
